10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from	to
Commission file number	1-367

THE L. S. STARRETT COMPANY

(Exact name of registrant as specified in its charter)

Massachusetts	04-1866480
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

121 Crescent Street, Athol, Massachusetts	01331-1915
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code 978-249-3551

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Common - $1.00 Per Share Par Value	SCX	New York Stock Exchange
Class B Common - $1.00 Per Share Par Value	Not applicable	Not applicable

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒     No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definition of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.  (Check One):

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer ☐ Smaller Reporting Company ☒

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐    No ☒

Common Shares outstanding as of	April 19, 2022
Class A Common Shares	6,666,824
Class B Common Shares	591,577

1

THE L. S. STARRETT COMPANY

CONTENTS

			Page No.
Part I.	Financial Information:
	Item 1.	Financial Statements	3
		Consolidated Balance Sheets – March 31, 2022 (unaudited) and June 30, 2021	3
		Consolidated Statements of Operations (unaudited)– three and nine months ended March 31, 2022 and March 31, 2021	4
		Consolidated Statements of Comprehensive Income (Loss) (unaudited) – three and nine months ended March 31, 2022 and March 31, 2021	5
		Consolidated Statements of Stockholders' Equity (unaudited) – three and nine months ended March 31, 2022 and March 31, 2021	6
		Consolidated Statements of Cash Flows (unaudited) - nine months ended March 31, 2022 and March 31, 2021	8
		Notes to Unaudited Consolidated Financial Statements	9-21
	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	20
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	27
	Item 4.	Controls and Procedures	27
Part II.	Other Information:
	Item 1A.	Risk Factors	28
	Item 6.	Exhibits	29
SIGNATURES			30

2

PART I.    FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

THE L. S. STARRETT COMPANY

Consolidated Balance Sheets

(in thousands except share data)

(unaudited)

	03/31/2022		06/30/2021
ASSETS
Current assets:
Cash	$	8,020	$	9,105
Accounts receivable (less allowance for doubtful accounts of $705 and $665, respectively)	41,415		35,076
Inventories	73,075		60,572
Prepaid expenses and other current assets	15,018		14,467
Total current assets	137,528		119,220
Property, plant and equipment, net	38,927		35,992
Right of use assets	5,606		4,298
Deferred tax assets, net	18,077		19,073
Intangible assets, net	4,713		4,888
Goodwill	1,015		1,015
Total assets	$	205,866	$	184,486
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current maturities of debt	$	22,832	$	15,959
Current lease liability	1,535		1,650
Accounts payable	17,908		17,229
Accrued expenses	11,091		8,811
Accrued compensation	5,590		8,040
Total current liabilities	58,956		51,689
Other tax obligations	3,024		2,866
Long-term lease liability	4,231		2,734
Long-term debt, net of current portion	9,405		6,010
Postretirement benefit and pension obligations	33,977		37,652
Total liabilities	109,593		100,951
Stockholders' equity:
Class A Common stock $1 par(20,000,000 shares authorized; 6,664,600 outstanding at March 31, 2022 and 6,475,307 outstanding at June 30, 2021)	6,665		6,475
Class B Common stock $1 par (10,000,000 shares authorized; 594,372 outstanding at March 31, 2022 and 633,505 outstanding at June 30, 2021)	594		634
Additional paid-in capital	56,948		56,507
Retained earnings	84,225		74,181
Accumulated other comprehensive loss	(52,159)		(54,262)
Total stockholders' equity	96,273		83,535
Total liabilities and stockholders’ equity	$	205,866	$	184,486

See Notes to Unaudited Consolidated Financial Statements

3

THE L. S. STARRETT COMPANY

Consolidated Statements of Operations

(in thousands except per share data)

(unaudited)

	3 Months Ended						9 Months Ended
	03/31/2022			03/31/2021			03/31/2022			03/31/2021
Net sales	$	60,479		$	54,944		$	183,311		$	158,408
Cost of goods sold	39,459			36,795			123,197			107,082
Gross margin	21,020			18,149			60,114			51,326
% of Net sales	34.8		%	33.0		%	32.8		%	32.4		%
Restructuring charges	658			788			658			1,518
Gain on sale of building	—			—			—			(3,204)
Selling, general and administrative expenses	14,988			13,511			45,750			41,126
Operating income	5,374			3,850			13,706			11,886
Other income, net	684			663			249			236
Income before income taxes	6,058			4,513			13,955			12,122
Income tax expense	1,774			1,496			3,911			1,132
Net income	$	4,284		$	3,017		$	10,044		$	10,990
Basic income per share	$	0.59		$	0.42		$	1.39		$	1.56
Diluted income per share	$	0.57		$	0.41		$	1.34		$	1.50
Weighted average outstanding shares used in per share calculations:
Basic	7,256			7,104			7,208			7,058
Diluted	7,492			7,390			7,480			7,335

See Notes to Unaudited Consolidated Financial Statements

4

THE L. S. STARRETT COMPANY

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

(unaudited)

	3 Months Ended				9 Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
Net income	$	4,284	$	3,017	$	10,044	$	10,990
Other comprehensive income (loss):
Currency translation gain (loss), net of tax	6,807		(3,835)		2,325		(225)
Pension and postretirement plans, net of tax	(89)		(60)		(222)		(81)
Other comprehensive income (loss)	6,718		(3,895)		2,103		(306)
Total comprehensive income (loss)	$	11,002	$	(878)	$	12,147	$	10,684

See Notes to Unaudited Consolidated Financial Statements

5

THE L. S. STARRETT COMPANY

Consolidated Statements of Stockholders' Equity

(in thousands) (unaudited)

For the Three and Nine-Month Period Ended March 31, 2022:

	Common Stock Outstanding				Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total
	Class A		Class B
Balance June 30, 2021	$	6,475	$	634	$	56,507	$	74,181	$	(54,262)	$	83,535
Total comprehensive income (loss)	—		—		—		3,232		(3,677)		(445)
Repurchase of shares	—		(2)		(14)		—		—		(16)
Stock-based compensation	119		—		55		—		—		174
Conversion	25		(25)		—		—		—		—
Balance September 30, 2021	$	6,619	$	607	$	56,548	$	77,413	$	(57,939)	$	83,248
Total comprehensive income (loss)	—		—		—		2,528		(938)		1,590
Repurchase of shares	—		—		(7)		—		—		(7)
Issuance of stock	7		8		102		—		—		117
Stock-based compensation	11		—		226		—		—		237
Conversion	7		(7)		—		—		—		—
Balance December 31, 2021	$	6,644	$	608	$	56,869	$	79,941	$	(58,877)	$	85,185
Total comprehensive income	—		—		—		4,284		6,718		11,002
Repurchase of shares	—		(3)		(14)		—		—		(17)
Stock-based compensation	10		—		93		—		—		103
Conversion	11		(11)		—		—		—		—
Balance March 31, 2022	$	6,665	$	594	$	56,948	$	84,225	$	(52,159)	$	96,273
Accumulated balance consists of:
Translation loss									$	(53,722)
Pension and postretirement plans, net of taxes									1,563
									$	(52,159)

6

THE L. S. STARRETT COMPANY

Consolidated Statements of Stockholders' Equity

(in thousands) (unaudited)

For the Three and Nine-Month Period Ended March 31, 2021:

	Common Stock Outstanding				Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total
	Class A		Class B
Balance June 30, 2020	$	6,308	$	680	$	55,762	$	58,648	$	(75,415)	$	45,983
Total comprehensive income (loss)	—		—		—		4,116		(258)		3,858
Repurchase of shares	—		(2)		(4)		—		—		(6)
Stock-based compensation	8		—		359		—		—		367
Conversion	26		(26)		—		—		—		—
Balance September 30, 2020	$	6,342	$	652	$	56,117	$	62,764	$	(75,673)	$	50,202
Total comprehensive income	—		—		—		3,857		3,847		7,704
Repurchase of shares	—		—		(1)		—		—		(1)
Issuance of stock	—		8		17		—		—		25
Stock-based compensation	103		—		51		—		—		154
Conversion	3		(3)		—		—		—		—
Balance December 31, 2020	$	6,448	$	657	$	56,184	$	66,621	$	(71,826)	$	58,084
Total comprehensive income (loss)	—		—		—		3,017		(3,895)		(878)
Repurchase of shares	—		(1)		(3)		—		—		(4)
Stock-based compensation	—		—		148		—		—		148
Conversion	4		(4)		—		—		—		—
Balance March 31, 2021	$	6,452	$	652	$	56,329	$	69,638	$	(75,721)	$	57,350
Accumulated balance consists of:
Translation loss									$	(62,099)
Pension and postretirement plans, net of taxes									(13,622)
									$	(75,721)

See Notes to Unaudited Consolidated Financial Statements

7

THE L. S. STARRETT COMPANY

Consolidated Statements of Cash Flows

(in thousands) (unaudited)

	9 Months Ended
	03/31/2022		03/31/2021
Cash flows from operating activities:
Net income	$	10,044	$	10,990
Non-cash operating activities:
Gain from sale of real estate	—		(3,204)
Depreciation	3,913		3,912
Amortization	957		911
Stock-based compensation	514		669
Net long-term tax obligations	126		117
Deferred taxes	937		(2,279)
Postretirement benefit and pension obligations	(1,058)		(11)
Changes in operating assets and liabilities:
Accounts receivable	(5,900)		(4,580)
Inventories	(11,053)		1,391
Other current assets	(5)		(1,813)
Other current liabilities	139		2,803
Prepaid pension expense	(2,342)		(6,374)
Other	937		189
Net cash (used in) provided by operating activities	(2,791)		2,721
Cash flows from investing activities:
Purchases of property, plant and equipment	(6,883)		(4,048)
Software development	(782)		(849)
Proceeds from sale of real estate	—		5,214
Net cash (used in) provided by investing activities	(7,665)		317
Cash flows from financing activities:
Proceeds from borrowings	39,875		12,581
Debt repayments	(29,488)		(17,924)
Proceeds from common stock issued	117		25
Shares repurchased	(40)		(11)
Net cash provided by (used in) financing activities	10,464		(5,329)
Effect of exchange rate changes on cash	(1,093)		80
Net decrease in cash	(1,085)		(2,211)
Cash, beginning of period	9,105		13,458
Cash, end of period	$	8,020	$	11,247
Supplemental cash flow information:
Interest paid	$	690	$	673
Income taxes paid, net	2,614		3,535

See Notes to Unaudited Consolidated Financial Statements

8

THE L. S. STARRETT COMPANY

Notes to Unaudited Consolidated Financial Statements

March 31, 2022

Note 1:    Basis of Presentation and Summary of Significant Account Policies

The unaudited interim consolidated financial statements as of and for the nine months ended March 31, 2022 have been prepared by The L.S. Starrett Company (the “Company”) in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements.  These unaudited consolidated financial statements, which, in the opinion of management, reflect all adjustments (including normal recurring adjustments) necessary for a fair presentation, should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021. The balance sheet as of June 30, 2021 has been derived from the audited consolidated financial statements as of and for the year ended June 30, 2021.  Operating results are not necessarily indicative of the results that may be expected for any future interim period or for the entire fiscal year. The Company’s “fiscal year” begins July 1st and ends June 30th.

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect amounts reported in the consolidated financial statements and accompanying notes.  Note 2 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended June 30, 2021 describes the significant accounting policies and methods used in the preparation of the consolidated financial statements.

Throughout the pandemic crisis, the Company's main focus has been on protecting the health and well-being of its employees, and the long-term financial health of the Company. It remains very difficult for management to predict when this crisis will no longer be a risk to future sales and operations. To the extent that pandemic-related events do not provide evidence about conditions that existed at the balance-sheet date, the Company considers it necessary to disclose it cannot estimate all aspects of the impact on the financial statements as a result of the on-going pandemic.

Note 2:    Segment Information

The segment information and the accounting policies of each segment are the same as those described in the notes to the consolidated financial statements entitled “Financial Information by Segment & Geographic Area” included in our Annual Report on Form 10-K for the year ended June 30, 2021. The Company’s business is aggregated into two reportable segments based on geography of operations: North American Operations and International Operations. Segment income is measured for internal reporting purposes by excluding corporate expenses, which are included in the unallocated column in the table below. Other income and expense, including interest income and expense, and income taxes are excluded entirely from the table below. There were no significant changes in the segment operations or in the segment assets from the Annual Report. Financial results for each reportable segment are as follows (in thousands):

	North American Operations		International Operations		Unallocated		Total
Three Months ended March 31, 2022
Sales1	$	36,288	$	24,191	$	—	$	60,479
Operating Income (Loss)	$	4,663	$	2,627	$	(1,917)	5,374
Three Months ended March 31, 2021
Sales2	$	32,519	$	22,425	$	—	$	54,944
Operating Income (Loss)	$	2,931	$	2,692	$	(1,773)	$	3,850

1.Excludes $1,148 of North American segment intercompany sales to the International segment, and $4,402 of International segment intercompany sales to the North American segment.

2.Excludes $1,338 of North American segment intercompany sales to the International segment, and $3,197 of International segment intercompany sales to the North American segment.

9

	North American Operations		International Operations		Unallocated		Total
Nine Months ended March 31, 2022
Sales1	$	102,763	$	80,548	$	—	$	183,311
Operating Income (Loss)	$	8,713	$	10,604	$	(5,611)	$	13,706
Nine months ended March 31, 2021
Sales2	$	85,609	$	72,799	$	—	$	158,408
Operating Income (Loss)	$	8,611	$	8,804	$	(5,529)	$	11,886

1.Excludes $2,827 of North American segment intercompany sales to the International segment, and $14,150 of International segment intercompany sales to the North American segment.

2.Excludes $3,075 of North American segment intercompany sales to the International segment, and $8,593 of International segment intercompany sales to the North American segment.

Note 3:    Revenue from Contracts with Customers

Under ASC Topic 606, the Company is required to present a refund liability and a return asset within the Unaudited Consolidated Balance Sheet. As of March 31, 2022 and June 30, 2021, the balance of the return asset was $0.1 million and $0.2 million, respectively, and the balance of the refund liability as of March 31, 2022 and June 30, 2021 was $0.2 million. They are presented within prepaid expenses and other current assets and accrued expenses, respectively, on the Consolidated Balance Sheets.

The Company, in general, warrants its products against certain defects in material and workmanship when used as designed, for a period of up to one year. The Company does not sell extended warranties.

Contract Balances

Contract assets primarily relate to the Company’s rights to consideration for work completed but not billed at the reporting date on contracts with customers. Contract assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been met, and therefore, revenue has not been recognized. The Company had no contract asset balances, but had contract liability balances of $0.9 million and $0.6 million at March 31, 2022 and June 30, 2021, respectively, located in Accounts Payable in the Consolidated Balance Sheets.

Disaggregation of Revenue

The Company operates in two reportable segments: North America and International. ASC Topic 606 requires further disaggregation of an entity’s revenue. In the following table, the Company's net sales by shipping origin are disaggregated accordingly for the three months ended March 31, 2022 and 2021 (in thousands):

10

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
North America
United States	$	34,181	$	30,307	$	97,049	$	79,989
Canada & Mexico	2,107		2,212		5,714		5,620
	36,288		32,519		102,763		85,609
International
Brazil	15,980		14,901		54,063		47,302
United Kingdom	4,750		4,269		14,254		14,818
China	1,899		1,655		5,761		5,240
Australia & New Zealand	1,562		1,600		6,469		5,439
	24,191		22,425		80,548		72,799
Total Sales	$	60,479	$	54,944	$	183,311	$	158,408

Note 4:    Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard will replace today’s “incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The amendment will affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2018-19 clarifies that receivables arising from operating leases are accounted for using lease guidance and not as financial instruments. The amendments should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. This ASU is effective for annual periods beginning after December 15, 2019, and interim periods therein. Early adoption was permitted for annual periods beginning after December 15, 2018, and interim periods therein. This pronouncement was extended for Small Reporting Companies and for the Company to July 1, 2022. The adoption of this standard does not have a material impact on the financial position and results of operations.

In August 2018, the FASB issued ASU No. 2018-14, "Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans." ASU 2018-14 removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and added additional disclosures. This ASU was effective for the Company beginning July 1, 2021 and applied on a retrospective basis. The adoption of this standard did not have a material impact on the financial position and results of operations or the required disclosures.

Note 5:    Leases

Operating lease cost amounted to $0.5 million and $2.1 million for the three and nine months period ended March 31, 2022 and $0.6 million and $1.8 million for the three and nine months period ended December 31, 2021. As of March 31, 2022, the Company’s right-of-use assets "ROU", lease obligations and remaining cash commitment on these leases (in thousands):

11

	Right-of-Use Assets	Operating Lease Obligations	Remaining Cash Commitment
Operating leases	$5,606	$5,766	$6,925

In March, the Company adopted a restructuring plan to close down Starrett Japan and Singapore operating units and continue to service that region out of Brazil and China with company agents servicing those countries. In the June quarter the Company expects to reduce its ROU asset and liabilities $0.1 million.

In September 2021, the Company entered into a six year lease in China for 100,682 square feet and recorded a right-of-use asset for $2.6 million. In July 2021, Starrett UK leased space to another company for annual rent of $0.2 million and incremental applicable service charges. The lease is a 20 year agreement with a contract review in 2026. The fees are recorded in Other Income in the Company's Consolidated Statement of Operations.

The Company has other operating lease agreements with commitments of less than one year or that are not significant. The Company elected the practical expedient option and as such, these lease payments are expensed as incurred. The Company’s weighted average discount rate and remaining term on lease liabilities is approximately 9.0% and 4.4 years. As of March 31, 2022, the Company’s financing leases are de minimis. The foreign exchange impact affecting the operating leases was de minimis in the March quarter and $0.1 million for the nine months ending March 31, 2022.

The Company entered into $0.2 million and $2.8 million in new operating lease commitments.

At March 31, 2022, the Company had the following fiscal year minimum operating lease commitments (in thousands)

Nine months ended March 31, 2022	Operating Lease Commitments
2022 (Remainder of year)	$552
2023	1,813
2024	1,541
2025	1,143
2026	1,050
Thereafter	826
Subtotal	$6,925
Imputed interest	(1,159)
Total	5,766

Note 6:    Stock-based Compensation

On September 5, 2012, the Board of Directors adopted The L.S. Starrett Company 2012 Long Term Incentive Plan (the “2012 Stock Plan”). The 2012 Stock Plan was approved by shareholders on October 17, 2012 and the material terms of its performance goals were re-approved by shareholders at the Company’s Annual Meeting held on October 18, 2017. There are no shares available under the 2012 Plan.

On September 1, 2021, the Board of Directors adopted The L.S. Starrett Company 2021 Long Term Incentive Plan (the “2021 Stock Plan”). The 2021 Stock Plan was approved by shareholders on October 13, 2021.

Both the 2012 and 2021 Stock Plan permits the granting of the following types of awards to officers, other employees and non-employee directors: stock options; restricted stock awards; unrestricted stock awards; stock appreciation rights; stock units including restricted stock units; performance awards; cash-based awards; and awards other than previously described that are convertible or otherwise based on stock. The 2021 and 2012 Stock Plans provide for the issuance of up to 500,000 shares of common stock.

12

Under both plans, options granted vest in periods ranging from one year to three years and expire ten years after the grant date. Restricted stock units (“RSU”) granted generally vest from one year to three years. Vested restricted stock units will be settled in shares of common stock. As of March 31, 2022, there were no stock options and 196,307 restricted stock units outstanding. There were 441,901 shares available for grant under the 2021 Stock Plan as of March 31, 2022.

For stock option grants, the fair value of each grant is estimated at the date of grant using the Binomial Options pricing model. The Binomial Options pricing model utilizes assumptions related to stock volatility, the risk-free interest rate, the dividend yield, and employee exercise behavior. Expected volatilities utilized in the model are based on the historic volatility of the Company’s stock price. The risk-free interest rate is derived from the U.S. Treasury Yield curve in effect at the time of the grant. The expected life is determined using the average of the vesting period and contractual term of the options (Simplified Method).

No stock options were granted during the nine months ended March 31, 2022 and 2021.

There were no stock options outstanding as of March 31, 2022. There were no stock options exercisable as of March 31, 2022. In recognizing stock compensation expense for the 2012 and 2021 Stock Incentive Plan, management has estimated that there will be no forfeitures of options.

The Company accounts for stock options and RSU awards by recognizing the expense of the grant date fair value ratably over vesting periods generally ranging from one year to three years. The related expense is included in selling, general and administrative expenses.

There were 80,500 RSU awards with a fair value of $11.35 per RSU granted during the nine months ended March 31, 2022. There were 133,995 RSUs settled, and 11,174 RSUs forfeited during the nine months ended March 31, 2022.  The aggregate intrinsic value of RSU awards outstanding as of March 31, 2022 was $1.5 million. As of March 31, 2022, all vested awards have been issued and settled.

On February 5, 2013, the Board of Directors adopted The L.S. Starrett Company 2013 Employee Stock Ownership Plan (the “2013 ESOP”). The purpose of the plan is to supplement existing Company programs through an employer funded individual account plan dedicated to investment in common stock of the Company, thereby encouraging increased ownership of the Company while providing an additional source of retirement income.  The plan is intended as an employee stock ownership plan within the meaning of Section 4975 (e) (7) of the Internal Revenue Code of 1986, as amended. U.S. employees who have completed a year of service are eligible to participate. There are no longer any new entrants into this plan.

Compensation expense related to all stock-based plans for the three and nine-month periods ended March 31, 2022 were $0.1 million and $0.4 million as compared to the prior year three and nine months of $0.1 million and $0.6 million, respectively.  As of March 31, 2022, there was $2.8 million of total unrecognized compensation costs related to outstanding stock-based compensation arrangements. Of this cost, $2.1 million relates to performance based RSU grants that are not expected to be awarded. The remaining $0.7 million is expected to be recognized over a weighted average period of 2.0 years.

Note 7:    Inventories

Inventories consist of the following (in thousands):

	03/31/2022		06/30/2021
Raw material and supplies	$	36,064	$	29,271
Goods in process and finished parts	21,627		16,096
Finished goods	41,752		37,344
	99,443		82,711
LIFO Reserve	(26,368)		(22,139)
	$	73,075	$	60,572

Of the Company’s $73.1 million and $60.6 million total inventory at March 31, 2022 and June 30, 2021, respectively, the $26.4 million and  $22.1 million LIFO reserves belong to the U.S. Precision Tools and Saws Manufacturing “Core U.S.” business. The Core U.S. business total inventory was $37.5 million on a FIFO basis and $11.2 million on a LIFO basis at March 31, 2022. The Core U.S. business had total Inventory, on a FIFO basis, of $27.9 million and $5.7 million on a LIFO

13

basis as of June 30, 2021. The use of LIFO, as compared to FIFO, resulted in a $4.3 million increase in cost of sales for the goods sold in the period ending March 31, 2022 compared to $0.4 million increase in the nine months ended March 31, 2021.

Note 8:    Goodwill and Intangible Assets

The Company’s acquisition of Bytewise in 2011 and a private software company in 2017 resulted in the recognition of goodwill totaling $4.7 million. During the fourth quarter of fiscal year 2020 the Company tested impairment of intangible assets according to ASC 360 "Property, Plant and Equipment" and determined the carrying value was deemed to be recoverable at Bytewise but not at the private software company where the impairment of intangibles was calculated. The Company concluded that intangible assets of the private software company were impaired by $2.9 million.

The Company then, according to ASC 350 Intangibles -Goodwill and Other, conducted a step one analysis performed based on the update carrying value for each reporting unit. Goodwill was determined to be impaired $0.6 million at the private software company and Goodwill of $3.0 million was impaired at the Bytewise reporting unit as of June 30, 2020. As a result, the balance of Goodwill at Bytewise is zero and $1.0 million at the private software company as of December 31, 2020.

The Company will continue to perform an annual assessment of goodwill associated with its purchase of a private software company. If future results significantly vary from current estimates, related projections, or business assumptions due to changes in industry or market conditions, the Company may be required to perform an impairment analysis prior to our annual test date if a triggering event is identified. As of March 31, 2022 , the Company did not identify a triggering event.

Amortizable intangible assets consist of the following (in thousands):

	03/31/2022		6/30/2021
Trademarks and trade names	2,070		2,070
Completed technology	—		2,010
Customer relationships	630		630
Software development	11,025		10,244
Total	13,725		14,954
Accumulated amortization and impairment	(9,012)		(10,066)
Total net balance	$	4,713	$	4,888

The category completed technology became fully amortized in November 2021. Amortizable intangible assets are being amortized on a straight-line basis over the period of expected economic benefit.

The estimated useful lives of the intangible assets subject to amortization range between 5 years for software development and 20 years for some trademark and trade name assets. The estimated aggregate amortization expense for the remainder of fiscal 2021 and for each of the next five years and thereafter, is as follows (in thousands):

2022 (Remainder of year)	$	359
2023	1,309
2024	1,039
2025	879
2026	669
2027	298
Thereafter	160
Total net balance	$	4,713

Note 9:    Pension and Post-retirement Benefits

The Company has two defined benefit pension plans, one for U.S. employees and another for U.K. employees.  The Company has a postretirement medical insurance benefit plan for U.S. employees. The Company also has defined contribution plans.

The U.K. defined benefit plan was closed to new entrants in fiscal 2009.

14

On December 21, 2016, the Company amended the U.S. defined benefit pension plan to freeze benefit accruals effective December 31, 2016. Consequently, the Plan is closed to new participants and current participants will no longer earn additional benefits after December 31, 2016.

Net periodic benefit costs for the Company's defined benefit pension plans are located in Other (expense), net in Consolidated Statements of Operations except (in the table below) for service cost. Service cost are in cost of sales and selling, general and administrative expenses. Net periodic benefit costs consist of the following (in thousands):

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
Interest cost	1,026		1,120		3,090		3,351
Expected return on plan assets	(1,092)		(1,115)		(3,290)		(3,336)
Amortization of net loss	14		13		42		40
	$	(52)	$	18	$	(158)	$	55

Net periodic benefit costs for the Company's Postretirement Medical Plan consists of the following (in thousands):

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
Service cost	$	9	$	21	$	27	$	64
Interest cost	12		51		37		154
Amortization of prior service credit	(369)		(134)		(1,106)		(403)
Amortization of net loss	48		41		142		124
	$	(300)	$	(21)	$	(900)	$	(61)

For the three months ended March 31, 2022 the Company did not contribute in the U.S. to the pension plan and contributed $0.3 million in the UK. For the nine month periods ended March 31, 2022, the Company contributed $1.5 million, in the U.S. and $0.8 million in the UK pension plans. Based upon the actuarial valuations performed on the Company’s defined benefit plans as of June 30, 2021, the contribution for fiscal 2022 for the U.S. plans would require a contribution of $5.6 million and the U.K. plan would require one of $1.0 million. However, as a result of the American Rescue Plan Act of 2021, the minimum required company contribution for the U.S. Plan in fiscal 2022 was reduced from $5.6 million to $0.6 million. The Company believes that government regulation is only a small part of deciding the pension funding, and as a result, has contributed more than the federal requirement. The Company will evaluate the U.S. future contribution on a quarterly basis.

The Company’s pension plans use fair value as the market-related value of plan assets and recognize net actuarial gains or losses in excess of ten percent (10)% of the greater of the market-related value of plan assets or of the plans’ projected benefit obligation in net periodic (benefit) cost as of the plan measurement date. Net actuarial gains or losses that are less than 10% of the thresholds noted above are accounted for as part of accumulated other comprehensive loss.

Note 10:     Debt

Debt is comprised of the following (in thousands):

	03/31/2022		06/30/2021
Short-term and current maturities
Loan and Security Agreement (Line of credit)	15,013		9,153
Loan and Security Agreement (Term Loan)	1,660		1,509
Brazil Loans	6,159		5,297
	22,832		15,959
Long-term debt (net of current portion)
Loan and Security Agreement (Term Loan)	4,758		6,010
Brazil Loans	4,647		—
	9,405		6,010
	$	32,237	$	21,969

15

See Note 12 Subsequent events: On April 29, 2022, the Company and certain of the Company’s domestic subsidiaries entered into a new Loan and Security agreement with HSBC Bank USA.

On December 31, 2019, the Company entered into the Tenth Amendment of its Loan and Security Agreement (“Tenth Amendment”). Under the revised agreement, the credit limit for the Revolving Loan was increased from $23.0 million to $25.0 million. In addition, the Company entered into a new $10.0 million 5-year Term Loan with a fixed interest rate of 4.0%. Under the Tenth Amendment, the credit limit for external borrowing was increased from $2.5 million to $5.0 million.

On June 25, 2020, the Borrowers and TD Bank entered into an amendment and restatement (the “Amendment and Restatement”) of the Loan Agreement. The Amendment and Restatement waived the fixed charge coverage ratio for the quarter ended June 30, 2020. In addition, the Amendment and Restatement clarifies that certain non-cash adjustments to the definition of EBITDA are permitted under the Loan Agreement, as amended. In addition, the Amendment and Restatement increases the permitted borrowings from a foreign bank from $5.0 million to $15.0 million and permits the Company to draw the remainder of the outstanding balance under the Loan Agreement.

Pursuant to the terms of the Company’s Amended and Restated Loan and Security Agreement of June 25, 2020, the “First Amendment” to this loan agreement was executed on September 17, 2020, which include, among other things, (i) pause testing of the Fixed Charge Coverage Ratio until September 30, 2021 and (ii) establishment of a new minimum cumulative EBITDA and minimum liquidity covenants in lieu thereof. TD Bank updated its security interests in the Company’s U.S. based assets, increased the maximum interest charged on the Line Of Credit from an annual interest rate of 2.25% plus Libor to 3.50% plus Libor, and amended the borrowing base for the line of credit from 80% of Qualified AR and 50% of the lower of Cost or Market of US inventory values to 80% of qualified AR plus 85% of the Net Orderly Liquidation Value (NOLV) of US Inventory plus 62.5% of total appraised US real estate values.

As a result of this change, the Company is projected to maintain its current borrowing capacity of $25,000,000 under the Line of Credit. The Company underwent a series of appraisals and field exams in all US locations as part of restructuring this agreement and will provide additional reporting supporting the borrowing base and covenants certifications. This minimum adjusted EBITDA covenant was based on the Company’s plan for a slow pandemic recovery throughout FY21 and the impact of the Company’s restructuring plan initiatives. As of September 30, 2021, the agreement has reverted to the prior covenant package. The Company was compliant with the minimum liquidity requirement and the minimum fixed charge coverage ratio required bank covenants as of March 31, 2022.

Total debt increased $10.3 million during the nine months ended March 31, 2022, $5.5 million of which was an increase in Brazil. This is in response to increased working capital levels required to meet strong customer demand and counteract pandemic related supply chain disruptions and increased transit times.

During the nine months ended March 31, 2022 the Brazilian subsidiary realized a build-up of ICMS (sales tax) credits, a consequence of the fiscal 2021 restructuring activities which increased the manufacturing activity and, therefore, raw material imports into Brazil. As the Company's Brazilian subsidiary is now exporting a larger proportion of its sales, its ability to re-claim these ICMS credits has been diminished. The Company is actively mitigating this consequence by filing applications with the relevant tax authorities to change the methodology of charging and re-claiming ICMS on imports and domestic sales so that this credit is subsequently relieved and does not increase at this rate again. This new methodology is common for similar sized, export focused companies in Brazil.

Availability under the Line of Credit remains subject to a borrowing base comprised of Accounts Receivable, Inventory, and Real Estate. The Company believes that the borrowing base will consistently produce availability under the Line of Credit of $25.0 million. A 0.25% commitment fee is charged on the unused portion of the Line of Credit.

The Company’s Brazilian subsidiary incurs short-term loans with local banks in order to support the Company’s strategic initiatives. The loans are backed by the entity’s US dollar denominated export receivables. The Company’s Brazilian subsidiary has the following loans of March 31, 2022 (in thousands):

16

Lending Institution	Interest Rate	Beginning Date	Ending Date	Outstanding Balance
Banco do Brasil SA	2.80%	May 2021	May 2022	$	20
Banco Bradesco SA	1.88%	July 2021	July 2022	$	671
Banco Bradesco SA	2.05%	August 2021	July. 2022	$	284
Banco Santander (Brasil) S.A	2.15%	August 2021	July 2022	$	399
Banco do Brasil SA	2.10%	August 2021	August 2022	$	1,299
Banco Itaú Unibanco	4.52%	October 2021	September 2024	$	4,000
Banco Santander (Brasil) S.A	2.71%	December 2021	July 2022	$	1,000
Banco Bradesco SA	2.05%	January 2022	January 2023	$	1,000
Banco Itaú Unibanco	4.98%	February 2022	February 2024	2,133
				$	10,806

Note 11:     Income Taxes

The Company is subject to U.S. federal income tax and various state, local, and foreign income taxes in numerous jurisdictions. The Company’s domestic and foreign tax liabilities are subject to the allocation of revenues and expenses in different jurisdictions and the timing of recognizing revenues and expenses. Additionally, the amount of income taxes paid is subject to the Company’s interpretation of applicable tax laws in the jurisdictions in which it files.

The Company provides for income taxes on an interim basis based on an estimate of the effective tax rate for the year. This estimate is reassessed on a quarterly basis. Discrete tax items are accounted for in the quarterly period in which they occur.

On December 22, 2017, the Tax Cuts and Jobs Act was enacted in the United States. The Act reduces the U.S. federal corporate tax rate from a graduated rate of 35% to a flat rate of 21%, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred and creates new taxes on certain foreign sourced earnings. Beginning in fiscal 2019, the Company incorporated certain provisions of the Act in the calculation of the tax provision and effective tax rate, including the provisions related to the Global Intangible Low Taxed Income (“GILTI”), Foreign Derived Intangible Income (“FDII”), Base Erosion Anti Abuse Tax (“BEAT”), as well as other provisions, which limit tax deductibility of expenses.

The GILTI provisions have had the most significant impact to the Company. Under the new law, U.S. taxes are imposed on foreign income in excess of a deemed return on tangible assets of its foreign subsidiaries. In general, this foreign income will effectively be taxed at an additional 10.5% tax rate reduced by any available current year foreign tax credits. The ability to benefit foreign tax credits may be limited under the GILTI rules as a result of the utilization of net operating losses, foreign sourced income and other potential limitations within the foreign tax credit calculation.

In July 2020, the IRS issued final regulations and additional proposed regulations that address the application of the high-taxed exclusion from GILTI. Under these regulations, the Company can make an annual election to exclude from its GILTI inclusion, income from its foreign subsidiaries that’s effective income tax rate exceeds 18.9% for that year. The regulations must be applied for tax years beginning after July 23, 2020 but companies have the option to apply retroactively for tax years beginning after December 31, 2017 and before July 23, 2020. In the first quarter of fiscal 2021 the Company recognized a discrete tax benefit of ($2.7) million related to the impact of electing to apply the high-tax exclusion retroactively for fiscal year 2019 and fiscal year 2020.

For the three month period ended March 31, 2022, the Company recognized tax expense of $1.8 million on a profit before tax of $6.1 million or an effective tax rate of 29%. For the three month period ended March 31, 2021, the Company recognized tax expense of $1.5 million on a profit before tax of $4.5 million or an effective tax rate of 33%. The tax rate for both fiscal 2022 and fiscal 2021 was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by tax credits and permanent deductions generated from research expenses.

For the nine month period ended March 31, 2022, the Company recognized tax expense of $3.9 million on a profit before tax of $14.0 million or an effective tax rate of 28%. This was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI

17

provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by discrete tax benefits recognized from excess stock compensation deductions, tax credits, and permanent deductions generated from research expenses. For the nine month period ended March 31, 2021. the Company recognized tax expense of $1.1 million on a profit before tax of $12.1 million or an effective tax rate of 9%.This was lower than the U.S. statutory tax rate of 21% primarily due to the discrete benefits relating to legislation enacted during the first quarter of fiscal 2021 in the amount of ($2.7) million related to the impact of the GILTI high-tax exclusion and ($0.2) million related to the impact of the increase in UK corporate tax rate on the net deferred tax asset. Other factors impacting the tax rate include the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by tax credits and permanent deductions generated from research expenses.

U.S. Federal tax returns for years prior to fiscal 2018 are generally no longer subject to review by tax authorities; however, tax loss carryforwards from earlier years are still subject to adjustment. As of March 31, 2022, the Company has substantially resolved all open income tax audits and there were no other local or federal income tax audits in progress. In international jurisdictions including Australia, Brazil, Canada, China, Germany, Mexico, New Zealand, Singapore and the UK, which comprise a significant portion of the Company’s operations, the years that may be examined vary by country. The Company’s most significant foreign subsidiary in Brazil is subject to audit for the calendar years 2015 – present. During the next twelve months, it is possible there will be a reduction of $0.1 million in long-term tax obligations due to the expiration of the statute of limitations on prior year tax returns.

Accounting for income taxes requires estimates of future benefits and tax liabilities. Due to the temporary differences in the timing of recognition of items included in income for accounting and tax purposes, deferred tax assets or liabilities are recorded to reflect the impact arising from these differences on future tax payments. With respect to recorded tax assets, the Company assesses the likelihood that the asset will be realized by addressing the positive and negative evidence to determine whether realization is more likely than not to occur. If realization is in doubt because of uncertainty regarding future profitability, the Company provides a valuation allowance related to the asset to the extent that it is more likely than not that the deferred tax asset will not be realized. Should any significant changes in the tax law or the estimate of the necessary valuation allowance occur, the Company would record the impact of the change, which could have a material effect on the Company’s financial position.

No valuation allowance has been recorded for the Company’s U.S. federal and foreign deferred tax assets related to temporary differences included in taxable income. While the Company continues to believe that forecasted future taxable income provide sufficient evidence to, more likely than not, support the realization of the tax benefits provided by those differences; the impact of COVID-19 may significantly impact its ability to forecast future pre-tax earnings in certain jurisdictions.

In the U.S., a partial valuation allowance has been provided for foreign tax credit carryforwards due to the uncertainty of generating sufficient foreign source income to utilize those credits in the future and certain state net operating loss carryforwards that will expire in the near future unutilized.

Note 12: Restructuring

In March 2022, the Company adopted restructuring plans at a total projected cost of $1.6 million, of which $0.9 million related to the closure of its distribution and sales centers in Singapore and Japan, and $0.7 million for the refinancing of the Company's domestic credit facilities. The Company will continue to service Asia out of Brazil and China, and the plan is expected to be completed by June 30, 2022. The cost to close the Singapore and Japan operations is comprised of $0.6 million in headcount reduction, $0.2 in fixed asset and lease disposal, and $0.1 million in professional fees The Company anticipates an annualized savings reflected in the Consolidated Statements of Operations in Selling, General and Administrative expenses for this project of $0.6 million.

In the quarter ending March 31, 2022, the Company recorded $0.7 million in restructuring charges, of which $0.4 million was accrued and $0.1 million was incurred in relation to headcount reduction costs related to the Singapore and Japan closure and $0.2 million was incurred in relation to the refinancing of the Company's domestic credit facilities. Additional restructuring charges anticipated for both the Japan and Singapore closure and the residual amount for the refinancing of the Company's domestic credit facilities will be recorded as incurred in the quarter ending June 30, 2022.

18

Note 13: Contingencies

The Company is involved in certain legal matters, which arise, in the normal course of business. The Company does not believe it is reasonably possible that these matters will have a material impact on the Company's financial condition or cash flows

Note 14: Subsequent Events

On April 29, 2022, the Company and certain of the Company’s domestic subsidiaries entered into a new Loan and Security agreement with HSBC Bank USA.

These new credit facilities replaced the Company’s previous TD Bank credit facilities and are comprised of a $30 million revolving line of credit with a $10 million uncommitted accordion provision, a $12.1 million term loan and a $7 million Capital Expenditure draw down credit facility. The Facilities are secured by a valid first-priority security interest on substantially all existing and future assets of the Company and its domestic subsidiaries.

The interest rate on the new facilities is based on a grid which uses the percentage of the remaining availability of the revolving credit line to determine the floating margin to be added to the one month or three-month Secured Overnight Financing Rate, herein "SOFR". The initial rate for the first three months of the agreement is the one-month SOFR plus 1.60%. The new credit facilities mature on April 29, 2027.

Availability under the revolving line of credit is secured by and subject to a borrowing base comprised of eligible inventory and accounts receivable. The percentage of receivables included in the borrowing base is 90% for domestic investment grade and foreign insured accounts, 85% for domestic accounts that are neither investment grade nor insured, and 75% of foreign uninsured accounts. The percentage of inventory included in the borrowing base is the lower of 65% of the value of eligible inventory at cost or 85% of the net orderly liquidation value of eligible inventory at cost. The initial borrowing base is estimated at about $19 million. Receivables and inventory are reported monthly to HSBC and subject to an annual field exam and inventory appraisal by an independent auditor commissioned by the Bank. The Company believes that the agreement provides an initial borrowing base sufficient for current domestic working capital needs and flexibility to accommodate potential growth-related working capital needs.

Availability under the Term Loan facility was comprised of 70% of the fair market value of the Borrowers’ eligible real estate, which included facilities located in Westlake, Ohio, and Waite Park, Minnesota and totaled $4.6 million; and 85% of the net orderly liquidation value of the Borrowers’ machinery and equipment, capped at $7.5 million. The real estate portion of the Term facility is subject to a 12.5 year straight line amortization paid quarterly, and the machinery and equipment portion of the facility is subject to a 6.67 year straight line amortization, also paid quarterly. The term loan is subject to equal quarterly installments of $373,650, payable on the last day of each fiscal quarter.

The capital expenditure loan facility is available for the purchase of new machinery and equipment at 80% of the net invoice value of new machinery and equipment purchases, with a draw period of eighteen months past the closing date, with any amount outstanding under the facility subject to a 3.75% amortization rate per quarter.

The new credit facilities contain financial covenants with respect to a minimum fixed charge coverage ratio of 1.00, measured on a trailing twelve-month basis, for both the U.S. borrowing companies tested quarterly and the Consolidated L.S. Starrett Company tested semi-annually. The Loan and Security agreement also contains the customary affirmative and negative covenants, including limitations on indebtedness, liens, acquisitions, asset dispositions, fundamental corporate changes, excess pension contributions, and certain customary events of default. Upon the occurrence or continuation of an event of default, the Lender may terminate all commitments and facilities, and require the immediate payment of the entire unpaid principal balances, accrued interest, and all other obligations.

19

ITEM 2.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

Use of Non- GAAP Financial Measures

In "Management's discussion and analysis on financial condition and results of operations" in this quarterly report on Form 10-Q, we discuss non- GAAP financial measures related to currency-neutral sales, as well as adjusted operating income.

We present these non- GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis by eliminating items that we do not believe are indicative of our core operating performance. Such non- GAAP financial measures assist investors in understanding the ongoing operating performance of the Company by presenting financial results between periods on a more comparable basis. Such measures should be considered in addition to, and not in lieu of, the financial measures calculated and presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Currency-neutral numbers are calculated using actual exchange rates in use during the comparative prior year period to enhance the visibility of the underlying business trends excluding the impact of translation arising from foreign currency exchange rate fluctuations. Adjusted operating income adjusts for restructuring costs and the gain on the sale of assets in order to show comparative operational performance. We include a reconciliation of currency-neutral revenues and adjusted operating income to its comparable GAAP financial measures.

References to currency-neutral sales and adjusted operating income should not be considered in isolation or as a substitute for other financial measures calculated and presented in accordance with GAAP and may not be comparable to similarly titled non- GAAP financial measures used by other companies. In evaluating these non-GAAP financial measures, investors should be aware that in the future we may incur expenses or be involved in transactions that are the same as or similar to some of the adjustments in this presentation. Our presentation of non-GAAP financial measures should not be construed to imply that its future results will be unaffected by any such adjustments. Non-GAAP financial measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP.

Please see Note 2 regarding segment results of operations. The Company’s business is aggregated into two reportable segments based on geography of operations: North American Operations and International Operations. Segment income is measured for internal reporting purposes by excluding corporate expenses, which are included in the unallocated column in the following tables as well as Note 2. These tables above are included to better explain our consolidated operational performance by showing more detail by business segment and reconciling GAAP operating income and adjusted operating income.

The following table represents key results of operations on a consolidated basis for the three months and nine months ended March 31, 2022 and March 31, 2021:

20

	Three Months Ended										Nine Months Ended
(Amounts in thousands)	03/31/22			03/31/2021			$ Change favorable (unfavorable)		% Change		03/31/2022			03/31/2021			$ Change favorable (unfavorable)	% Change
Net sales	$	60,479		$	54,944		$	5,535	10.1	%	$	183,311		$	158,408		24,903	15.7	%
Gross margin	21,020			18,149			2,871		15.8	%	60,114			51,326			8,788	17.1	%
% of net sales	34.8		%	33.0		%					32.8		%	32.4		%
Selling, general and administrative expenses	14,988			13,511			(1,477)		(10.9)	%	45,750			41,126			(4,624)	(11.2)	%
% of net sales	24.8		%	24.6		%					25.0		%	26.0		%
Restructuring charges	658			788			130		(100.0)	%	658			1,518			860	(100.0)	%
Gain on sale of building	—			—			—		—	%	—			(3,204)			(3,204)	100.0	%
Operating income	5,374			3,850			1,524		39.6	%	13,706			11,886			1,820	15.3	%
Other income, net	684			663			21		3.1	%	249			236			13	(5.4)	%
Income before income taxes	6,058			4,513			1,545		34.2	%	13,955			12,122			1,833	15.1	%
Income tax expense	1,774			1,496			(278)		(18.6)	%	3,911			1,132			(2,779)	(245.5)	%
Net income	$	4,284		$	3,017		1,267		42.0	%	$	10,044		$	10,990		(946)	(8.6)	%

GAAP to Non-GAAP reconciliation:
	Three Months Ended							Nine Months Ended
(Amounts in thousands)	03/31/22		03/31/2021		$ Change favorable (unfavorable)	% Change		03/31/2022		03/31/2021		$ Change favorable (unfavorable)	% Change
Operating income as reported	5,374		3,850		1,524	39.6	%	13,706		11,886		1,820	15.3	%
Add back restructuring charges	658		788		(130)	(16.5)	%	658		1,518		(860)	(56.6)	%
Less gain on sale of building	—		—		—	—	%	—		(3,204)		3,204	100.0	%
Non- GAAP adjusted operating income	6,032		4,638		1,394	30.1	%	14,365		10,200		4,165	40.8	%
% of net sales	10.0	%	8.4	%				7.8	%	6.4	%

The following table represents key results of operations for three months ending March 31, 2022 and 2021 based on our business aggregated into two reportable segments according to geography of operations: North American Operations and International Operations as reflected in the table below:

21

	Three Months Ended March 31, 2022											Three Months Ended March 31, 2021
(Amounts in thousands)	North America			International			Corporate		Total			North America			International			Corporate		Total
Net sales	$	36,288		$	24,191		$	—	$	60,479		$	32,519		$	22,425		$	—	$	54,944
Gross margin	11,713			9,306			—		21,019			9,741			8,409					18,149
% of net sales	32.3		%	38.5		%			34.8		%	30.0		%	37.5		%			33.0		%
Selling, general and administrative expenses	6,789			6,282			1,917		14,989			6,627			5,111			1,772		13,510
% of net sales	18.7		%	26.0		%			24.8		%	20.4		%	22.8		%			24.6		%
Restructuring charges	261			397			—		658			182			606			—		788
Gain on sale of building	—			—			—		—			—			—			—		—
Operating income (loss)	$	4,663		$	2,627		$	(1,917)	$	5,373		$	2,932		$	2,692		$	(1,772)	$	3,851
% of net sales	12.9		%	10.9		%			8.9		%	9.0		%	12.0		%			7.0		%
Add back restructuring charges	261			397			—		658			182			606			—		788
Less gain on sale of building	—			—			—		—			—			—			—		—
Non-GAAP adjusted operating income	$	4,924		$	3,024		$	(1,917)	$	6,031		$	3,114		$	3,298		$	(1,772)	$	4,639
% of net sales	13.6		%	12.5		%			10.0		%	9.6		%	14.7		%			8.4		%

The following table represents key results of operations for nine months ending March 31, 2022 and 2021 based on our business aggregated into two reportable segments according to geography of operations : North American Operations and International Operations:

	Nine Months Ended March 31, 2022											Nine Months Ended March 31, 2021
(Amounts in thousands)	North America			International			Corporate		Total			North America			International			Corporate		Total
Net sales	$	102,763		$	80,548		$	—	$	183,311		$	85,609		$	72,800		$	—	$	158,408
Gross margin	29,568			30,545			—		60,113			24,500			26,826			—		51,326
% of net sales	28.8		%	37.9		%			32.8		%	28.6		%	36.8		%			32.4		%
Selling, general and administrative expenses	20,594			19,544			5,611		45,749			18,257			17,340			5,529		41,126
% of net sales	20.0		%	24.3		%			25.0		%	21.3		%	23.8		%			26.0		%
Restructuring charges	261			397			—		658			836			682			—		1,518
Gain on sale of building	—			—					—			(3,204)			—			—		(3,204)
Operating income (loss)	$	8,713		$	10,604		$	(5,611)	$	13,706		$	8,612		$	8,805		$	(5,529)	$	11,886
% of net sales	8.5		%	13.2		%			7.5		%	10.1		%	12.1		%			7.5		%
Add back restructuring charges	261			397			—		658			836			682			—		1,518
Less gain on sale of building	—			—			—		—			(3,204)			—			—		(3,204)
Non-GAAP adjusted operating income	$	8,974		$	11,001		$	(5,611)	$	14,364		$	6,244		$	9,486		$	(5,529)	$	10,200
% of net sales	8.7		%	13.7		%			7.8		%	7.3		%	13.0		%			6.4		%

22

US GAAP to NON-U.S. GAAP Reconciliation
(Amounts in Thousands)	Quarter Ended 3/31/2022	Comparison to Quarter Ended 12/31/2020				Fiscal 2022 YTD 3/31/2022	Comparison Fiscal 2021 YTD 3/31/2021
		3/31/2021	$ Change	% Change			3/31/2021	$ Change	% Change
Net Sales, as reported	$60,478	$54,944	$5,534	10.1	%	$183,310	$158,408	$24,902	15.7	%
Change when converting FY22 sales in non USD functional currencies at the same exchange rates used in the comparison period	(1,270)	-				(2,531)	-
FY22 Currency Neutral Net Sales	$59,208	$54,944	$4,264	7.8	%	$180,779	$158,408	$22,371	14.1	%

	Three Months Ended				Nine Month Ended
	03/31/22		03/31/2021		03/31/22		03/31/2021
Net income	$	4,284	$	3,017	$	10,044	$	10,990
Less Gain on sale	—		—		—		(3,204)
Less GILTI Recalculation 9-30-20	—		—		—		(2,608)
Non-GAAP adjusted Net Income	$	4,284	$	3,017	$	10,044	$	5,178
Shares diluted	7,492		7,390		7,480		7,335
Diluted EPS as reported	$	0.57	$	0.41	$	1.34	$	1.50
Non-GAAP adjusted diluted EPS	$	0.57	$	0.41	$	1.34	$	0.71

Three-month and Nine-month Periods Ended March 31, 2022 and March 31, 2021

Overview

New order intake remained strong across all areas of the business during the nine months ended March 31, 2022, representing an increase of over 21% compared to the nine months ended March 31, 2021 . As a result, backlog remained at historically high levels, over 69% higher as of March 31, 2022 compared to March 31, 2021. The Company expects this trend to continue throughout the remainder of Fiscal 2022.

Net sales in the three months ended March 31, 2022 were $60.5 million, an increase of $5.5 million, or 10.1% compared to $54.9 million in the three months ended March 31, 2021. Net Sales in the nine months ended March 31, 2022 were $183.3 million, compared to $158.4 million for the nine months ended March 31, 2021, representing an improvement of $24.9 million, or 15.7%.

Although foreign currency translation impact in aggregate has been minimal over the first nine months of Fiscal 2022, the United States Dollar has weakened in the quarter just ended on March 31, 2022, particularly in relation to the Brazilian Real. This has had the impact of inflating Net Sales by $2.5 million through the nine months ending on March 31, 2022. Currency neutral net sales for the three months ended March 31, 2022 were $59.2 million, an increase of $4.3 million or 7.8% compared to $54.9 million in the three months ended March 31, 2021. For the nine months ended March 31, 2022, currency neutral net sales were lower than reported sales at $180.8 million, representing an increase of $22.4 million, or 14.1% over the $158.4 million reported for the nine months ended March 31, 2021.

Operating income in the three months ended March 31, 2022 of $5.4 million or 8.9% of sales, was $1.5 million or 39.6% higher than the Operating income reported for three months ended March 31, 2021. Operating income in the nine months ended March 31, 2022 of $13.7 million was $1.8 million or 15.3% higher than the same period last year, which included a $3.2 million gain on the sale of the Mt. Airy, North Carolina building and $1.5 million of restructuring charges or $0.8 million more in restructuring than the nine months ended March 31, 2022. Eliminating the restructuring cost and the one-time gain on the sale of the Mt. Airy North Carolina facility from the nine months ended March 31, 2021 and the restructuring cost in nine

23

months ended March 31, 2022, non-GAAP adjusted operating income increased 40.8% or $4.2 million to $14.4 million which is 7.8% on sales of $183.3 million for the nine months ended March 31, 2022.

The Company continues to benefit from its restructuring activities completed in Fiscal 2021 that have resulted in a reduction of excess production capacity and selling, general and administrative expenses. However, pandemic related challenges have continued to evolve in relation to supply chain, freight costs, logistics, wage inflation and labor shortages which impact plant utilization in North America. These challenges are offsetting those restructuring gains in the short term, and are expected to continue throughout the remainder of fiscal 2022. In an effort to mitigate the impact of these challenges, the Company implemented price increases in the first quarter of fiscal 2022 in Brazil and in the U.S.. Additional price increases and surcharges on shipped orders were implemented on a rolling basis throughout the third quarter of fiscal 2022. Price increases and surcharges were successfully implemented and taking nearly full effect during the quarter ended March 31, 2022, resulting in an overall improvement of gross margin to 34.8%, representing an improvement of 390 basis points from the quarter ending December 31, 2021.

Net income for the three months ended March 31, 2022 was $4.3 million which included $0.7 million of restructuring expense, and was $1.3 million or 42.0% higher than the Net Income reported for the three months ended March 31, 2021 of $3.0 million which included $0.8 million of restructuring expense.

Net income for the nine months ended March 31, 2022 was $10.0 million, including $0.7 million of restructuring expense as compared to $11.0 million for the nine months ended March 31, 2021. The nine months ended March 31, 2021 included the $3.2 million gain on the sale of the Company’s Mt. Airy, North Carolina facility and $1.5 million of restructuring expense. Diluted earnings per share "EPS" were $0.57 compared to $0.41 in the three months ended March 31, 2022 versus the prior year. Diluted EPS were $1.34 compared to $1.50 in the nine months ended March 31, 2022 versus the prior year which included a gain of $3.2 million on a building sale and a $2.6 million GILTI tax credit in September 2020 . In removing those two items the Non-GAAP adjusted diluted EPS would be $0.71.

In March 2022, the Company adopted restructuring plans at a total projected cost of $1.6 million, of which $0.9 million related to the closure of its distribution and sales centers in Singapore and Japan, and $0.7 million for the refinancing of the Company's domestic credit facilities. The Company will continue to service Asia out of Brazil and China, and the plan is expected to be completed by June 30, 2022. The cost to close the Singapore and Japan operations is comprised of $0.6 million in headcount reduction, $0.2 in fixed asset and lease disposal, and $0.1 million in professional fees The Company anticipates an annualized savings reflected in the Consolidated Statements of Operations in Selling, General and Administrative expenses for this project of $0.6 million. (See Note 12 Restructuring)

The COVID pandemic has recently impacted our operation in Suzhou, China and still could have an impact globally. Along with the on-going global supply chain slowing, the Suzhou China operation is impacted by government controls as it relates to pandemic related cases and it affects the Company's ability to bring in material and ship finished product to third-party customers and Starrett intercompany partners. Currently, it has not materially affected the Company's Consolidated Statement of Operations, but it remains very difficult for management to predict pandemic related resolution. As a result, management continues its planning process and expects its Suzhou plant to continue to have logistical difficulties in the quarter ending June 30, 2022.

Net Sales

The Company’s net sales for the three months ended March 31, 2022 were $60.5 million versus $54.9 million for the same period a year prior. North America sales of $36.3 million represents an increase of $3.8 million or 11.6% in the quarter ended March 31, 2022. International Sales increase of $24.2 million during the quarter ended March 31, 2022 from $22.4 million during the quarter ended March 31, 2021, an increase of $1.8 million or 7.9%. The Company continues to achieve year on year sales growth across all geographical areas and product offerings.

During nine months ended March 31, 2022 as compared to 2021, North American sales increased $17.2 million or 20.0% while international sales increased $7.7 million or 10.6%. Consolidated Net Sales in the nine months ended March 31, 2022 were $183.3 million, compared to $158.4 million for the same nine months ended March 31, 2021, representing an improvement of $24.9 million, or 15.7%.

Gross Margin

24

Gross margin increased $2.9 million or 15.8% for the three months, and $8.8 million, or 17.1% for the nine months ended March 31, 2022 as compared to the year prior, primarily as a result of higher sales. Gross margin as a percentage of sales increased 1.7 percentage points for the three months, and increased 0.4 percentage points for the nine months ended March 31, 2022 compared to the prior year.

Although gross margins have generally improved, the evolution of many challenges related to the COVID-19 pandemic have partially offset the impact of the Company's restructuring activities. These include an increase in material and freight costs, and longer transit times which impact all sectors or the Company’s business. In North America, labor shortages and associated wage inflation continue to drive up costs and impact plant utilization. Although North American gross margin shows some improvement compared to the prior year, fiscal 2021 restructuring efforts are partially offset by the aforementioned labor shortages and wage inflation. International gross margin is more affected by material and freight cost increases, supply chain disruptions and increased transit times.

In an effort to mitigate the impact of these challenges, the Company implemented price increases in the first quarter of fiscal 2022 in Brazil and the U.S.. Additional price increases and surcharges on shipped orders were implemented on a rolling basis throughout the third quarter of fiscal 2022. Price increases and surcharges were implemented and took nearly full effect during the quarter ended March 31, 2022, resulting in an overall improvement of gross margin to 34.8%, which is an improvement of 390 basis points from the quarter ended December 31, 2021. The Company expects these trends to continue through the remainder of this fiscal year.

For the three months ended March 31, 2022, North American gross margin measured as a percent of net sales improved by 2.3 percentage points from 30.0% to 32.3%, compared to the three-month period ended March 31, 2021. International gross margin increased by 1.0 percentage point from 37.5% during the three-month period ended March 31, 2021 to 38.5% for the three-month period ended March 31, 2022 .

For the nine months ended March 31, 2022, North American gross margin measured as a percentage of Net Sales improved from 28.6% to 28.8%. International gross margin as a percentage of net sales also increased from 36.8% to 37.9% for the nine months ended from March 31, 2021 to March 31, 2022 respectively.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $1.5 million or 10.9% during the quarter ended March 31, 2022 compared to the quarter ended March 31, 2021, representing 24.8% of Net Sales for the quarter ended March 31, 2022 compared to 24.6% in the prior year quarter ended March 31, 2021 .

Selling, general and administrative expenses increased $4.6 million or 11.2% during nine months ended March 31, 2022 compared to 2021, however as a percentage of net sales it has declined from 26.0% for the nine months ended March 31, 2021 to 25.0% for the nine months ended March 31, 2021.

The Company has continued to benefit from selling, general and administrative reductions enacted as part of the fiscal 2021 restructuring programs, as evidenced in the decline of these costs as a percentage of net sales. This was partially offset by some variable selling costs tied to the higher level of sales, and temporary salary reductions enacted during the initial phase of the pandemic, which have since been restored.

Other Income (Expense)

For the three and nine months period ended March 31, 2022 other expense was $0.7 million and $0.2 million, respectively. For the three and nine months period ended March 31, 2021 other expense was $0.7 million and $0.2 million.

Income Taxes

For the three month period ended March 31, 2022, the Company recognized tax expense of $1.8 million on a profit before tax of $6.1 million or an effective tax rate of 29%. For the three month period ended March 31, 2021, the Company recognized tax expense of $1.5 million on a profit before tax of $4.5 million or an effective tax rate of 33%. The tax rate for both fiscal 2022 and fiscal 2021 was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by tax credits and permanent deductions generated from research expenses.

25

For the nine month period ended March 31, 2022, the Company recognized tax expense of $3.9 million on a profit before tax of $14.0 million or an effective tax rate of 28%. This was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by discrete tax benefits recognized from excess stock compensation deductions, tax credits, and permanent deductions generated from research expenses. For the nine month period ended March 31, 2021. the Company recognized tax expense of $1.1 million on a profit before tax of $12.1 million or an effective tax rate of 9%.This was lower than the U.S. statutory tax rate of 21% primarily due to the discrete benefits relating to legislation enacted during the first quarter of fiscal 2021 in the amount of ($2.7) million related to the impact of the GILTI high-tax exclusion and ($0.2) million related to the impact of the increase in UK corporate tax rate on the net deferred tax asset. Other factors impacting the tax rate include the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by tax credits and permanent deductions generated from research expenses.

LIQUIDITY AND CAPITAL RESOURCES

Cash flows (in thousands)	Nine Months Ended
	03/31/2022	03/31/2021
Cash (used in) provided by operating activities	(2,791)	2,721
Cash (used in) provided by investing activities	(7,665)	317
Cash provided by (used in) financing activities	10,464	(5,329)
Effect of exchange rate changes on cash	(1,093)	80
Net (decrease) in cash	$(1,085)	$(2,211)

Net cash flows for the nine months ended March 31, 2022 provided a decrease in cash of $1.1 million compared to a decrease in cash of $2.2 million for the nine months ended March 31, 2021. Cash used in operations was $2.8 million due to increases in working capital required to meet strong customer demand and counteract supply chain disruptions and increased transit times. The Company has invested $(6.9) million in new equipment and increased borrowing $10.4 million in the nine months ended March 31, 2022.

During the nine months ended March 31, 2022 the Brazilian subsidiary realized a build-up of ICMS (sales tax) credits, a consequence of the fiscal 2021 restructuring activities which increased the manufacturing activity and, therefore, raw material imports into Brazil. As the Company's Brazilian subsidiary is now exporting a larger proportion of its sales, its ability to re-claim these ICMS credits has been diminished. The Company is actively mitigating this consequence by filing applications with the relevant tax authorities to change the methodology of charging and re-claiming ICMS on imports and domestic sales so that this credit is subsequently relieved and does not increase at this rate again. This new methodology is common for similar sized, export focused companies in Brazil.

Liquidity and Credit Arrangements

The new credit facilities with HSBC replaced the Company’s previous TD Bank credit facilities and are comprised of a $30 million revolving line of credit, a $12.1 million term loan and a $7 million Capital Expenditure draw down credit facility. The Company believes that existing cash and cash expected to be provided by future operating activities, augmented by the plans highlighted above, are adequate to satisfy its working capital, capital expenditure requirements and other contractual obligations for at least the next 12 months. If the Company's expectations are incorrect or the impact from the COVID-19 pandemic worsens then it may need to take advantage of unanticipated strategic opportunities to strengthen our financial position, which could result in material impacts to the Company’s consolidated financial statements in future reporting periods.

The credit facilities contain financial covenants with respect to a minimum fixed charge coverage ratio of 1.00, measured on a trailing twelve-month basis, for both the U.S Borrowing companies tested quarterly and the Consolidated L.S. Starrett Company tested semi-annually. The Loan and Security agreement also contains the customary affirmative and negative covenants, including limitations on indebtedness, liens, acquisitions, asset dispositions, fundamental corporate changes, excess pension contributions, and certain customary events of default. Upon the occurrence or continuation of an event of default, the Lender may terminate all commitments and facilities, and require the immediate payment of the entire unpaid principal balances, accrued interest, and all other obligations. As of April 29, 2022, the Company was in compliance with all covenants required to be tested at that time.

26

The effective interest rate on the borrowings under the TD Bank Loan and Security Agreement during the nine months ended March 31, 2022 and 2021 was 1.9% and 1.9% respectively. The effective rate for the nine months ended March 31, 2021 was lower than that specified in the First Amendment to the loan agreement which was executed on September 17, 2020 (See Note 10).

OFF-BALANCE SHEET ARRANGEMENTS

The Company does not have any material off-balance sheet arrangements as defined under the Securities and Exchange Commission rules.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

One should carefully review and consider the information regarding certain factors which could materially affect our business, financial condition or future results set forth under Item 1A. “Risk Factors” in our Form 10-K for the year ended June 30, 2021.

ITEM 4.    CONTROLS AND PROCEDURES

The Company's management, under the supervision and with the participation of the Company's President and Chief Executive Officer and Chief Financial Officer and Treasurer, has evaluated the Company's disclosure controls and procedures as of March 31, 2022, and they have concluded that our disclosure controls and procedures were effective as of such date. All information required to be filed in this report was recorded, processed, summarized and reported within the time period required by the rules and regulations of the Securities and Exchange Commission, and such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the three months ended March 31, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

27

PART II.    OTHER INFORMATION

ITEM 1A.    RISK FACTORS

SAFE HARBOR STATEMENT

UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This Quarterly Report on Form 10-Q contains forward-looking statements about the Company’s business, competition, sales, expenditures, foreign operations, plans for reorganization, interest rate sensitivity, debt service, liquidity and capital resources, and other operating and capital requirements. In addition, forward-looking statements may be included in future Company documents and in oral statements by Company representatives to securities analysts and investors. The Company is subject to risks that could cause actual events to vary materially from such forward-looking statements. You should carefully review and consider the information regarding certain factors which could materially affect our business, financial condition or future results set forth under Item 1A. “Risk Factors” in our Form 10-K for the year ended June 30, 2021. There have been no material changes from the factors disclosed in our Form 10-K for the year ended June 30, 2021.

28

ITEM 6.    EXHIBITS

10a	The Loan and Security Agreement dated April 29, 2022 by and among the L.S. Starrett Company, Tru-Stone Technologies, Inc., Starrett Kinemetric Engineering, Inc. and Starrett Bytewise Developement, Inc. and HSBC Bank USA, National Association incorporated by reference.
31a	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
31b	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
32	Certifications of the Principal Executive Officer and the Principal Financial Officer pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following materials from The L. S. Starrett Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 are furnished herewith, formatted in XBRL (Extensible Business Reporting Language): (I) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income (Loss), (iv) the Consolidated Statement of Stockholders' Equity, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text.

29

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		THE L. S. STARRETT COMPANY (Registrant)
Date	May 9, 2022	/S/R. Douglas A. Starrett
		Douglas A. Starrett - President and CEO (Principal Executive Officer)
Date	May 9, 2022	/S/R. John C. Tripp
		John C. Tripp - Treasurer and CFO (Principal Accounting Officer)

30

EX-31.A

EXHIBIT 31.a

CERTIFICATIONS

I, Douglas A. Starrett, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of The L.S. Starrett Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial report; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 9, 2022	/S/	Douglas A. Starrett
		Douglas A. Starrett
		Chief Executive Officer

EX-31.B

EXHIBIT 31.b

CERTIFICATIONS

I, John C. Tripp, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of The L.S. Starrett Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial report; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 9, 2022	/S/	John C. Tripp
		John C. Tripp
		Chief Financial Officer

EX-32

EXHIBIT 32

CERTIFICATIONS

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of The L.S. Starrett Company, a Massachusetts corporation (the "Company"), does hereby certify, to such officer's knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (the "Form 10-Q") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date	May 9, 2022	/S/ Douglas A. Starrett
		Douglas A. Starrett
		Chief Executive Officer
Date	May 9, 2022	/S/ John C. Tripp
		John C. Tripp
		Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to The L.S. Starrett Company and will be retained by The L.S. Starrett Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover page - shares	9 Months Ended
	Mar. 31, 2022	Apr. 19, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	1-367
Entity Registrant Name	STARRETT L S CO
Entity Incorporation, State or Country Code	MA
Entity Tax Identification Number	04-1866480
Entity Address, Address Line One	121 Crescent Street
Entity Address, City or Town	Athol
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01331-1915
City Area Code	978
Local Phone Number	249-3551
Title of 12(b) Security	Class A Common - $1.00 Per Share Par Value
Trading Symbol	SCX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000093676
Amendment Flag	false
Class A Common Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,666,824
Class B Common Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		591,577

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Current assets:
Cash	$ 8,020	$ 9,105
Accounts receivable (less allowance for doubtful accounts of $705 and $665, respectively)	41,415	35,076
Inventories	73,075	60,572
Prepaid expenses and other current assets	15,018	14,467
Total current assets	137,528	119,220
Property, plant and equipment, net	38,927	35,992
Right of use assets	5,606	4,298
Deferred tax assets, net	18,077	19,073
Intangible assets, net	4,713	4,888
Goodwill	1,015	1,015
Total assets	205,866	184,486
Current liabilities:
Current maturities of debt	22,832	15,959
Current lease liability	1,535	1,650
Accounts payable	17,908	17,229
Accrued expenses	11,091	8,811
Accrued compensation	5,590	8,040
Total current liabilities	58,956	51,689
Other tax obligations	3,024	2,866
Long-term lease liability	4,231	2,734
Long-term debt, net of current portion	9,405	6,010
Postretirement benefit and pension obligations	33,977	37,652
Total liabilities	109,593	100,951
Stockholders' equity:
Additional paid-in capital	56,948	56,507
Retained earnings	84,225	74,181
Accumulated other comprehensive loss	(52,159)	(54,262)
Total stockholders' equity	96,273	83,535
Total liabilities and stockholders’ equity	205,866	184,486
Class A Common Shares
Stockholders' equity:
Common stock	6,665	6,475
Class B Common Shares
Stockholders' equity:
Common stock	$ 594	$ 634

XML

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Allowance for doubtful accounts	$ 705	$ 665
Class A Common Shares
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares, outstanding (in shares)	6,664,600	6,475,307
Class B Common Shares
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	10,000,000	10,000,000
Common stock, shares, outstanding (in shares)	594,372	633,505

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net sales	$ 60,479	$ 54,944	$ 183,311	$ 158,408
Cost of goods sold	39,459	36,795	123,197	107,082
Gross margin	$ 21,020	$ 18,149	$ 60,114	$ 51,326
% of Net sales	34.80%	33.00%	32.80%	32.40%
Restructuring charges	$ 658	$ 788	$ 658	$ 1,518
Gain on sale of building	0	0	0	(3,204)
Selling, general and administrative expenses	14,988	13,511	45,750	41,126
Operating income	5,374	3,850	13,706	11,886
Other income, net	684	663	249	236
Income before income taxes	6,058	4,513	13,955	12,122
Income tax expense	1,774	1,496	3,911	1,132
Net income	$ 4,284	$ 3,017	$ 10,044	$ 10,990
Basic income per share (in dollars per share)	$ 0.59	$ 0.42	$ 1.39	$ 1.56
Diluted income per share (in dollars per share)	$ 0.57	$ 0.41	$ 1.34	$ 1.50
Weighted average outstanding shares used in per share calculations:
Basic (in shares)	7,256	7,104	7,208	7,058
Diluted (in shares)	7,492	7,390	7,480	7,335

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 4,284	$ 3,017	$ 10,044	$ 10,990
Other comprehensive income (loss):
Currency translation gain (loss), net of tax	6,807	(3,835)	2,325	(225)
Pension and postretirement plans, net of tax	(89)	(60)	(222)	(81)
Other comprehensive income (loss)	6,718	(3,895)	2,103	(306)
Total comprehensive income (loss)	$ 11,002	$ (878)	$ 12,147	$ 10,684

XML

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock Outstanding Class A	Common Stock Outstanding Class B	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance at Jun. 30, 2020	$ 45,983	$ 6,308	$ 680	$ 55,762	$ 58,648	$ (75,415)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	3,858				4,116	(258)
Repurchase of shares	(6)		(2)	(4)
Stock-based compensation	367	8		359
Conversion	0	26	(26)
Ending balance at Sep. 30, 2020	50,202	6,342	652	56,117	62,764	(75,673)
Beginning balance at Jun. 30, 2020	45,983	6,308	680	55,762	58,648	(75,415)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	10,684
Ending balance at Mar. 31, 2021	57,350	6,452	652	56,329	69,638	(75,721)
Beginning balance at Sep. 30, 2020	50,202	6,342	652	56,117	62,764	(75,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	7,704				3,857	3,847
Repurchase of shares	(1)			(1)
Stock-based compensation	154	103		51
Conversion	0	3	(3)
Issuance of stock	25		8	17
Ending balance at Dec. 31, 2020	58,084	6,448	657	56,184	66,621	(71,826)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	(878)				3,017	(3,895)
Repurchase of shares	(4)		(1)	(3)
Stock-based compensation	148			148
Conversion	0	4	(4)
Ending balance at Mar. 31, 2021	57,350	6,452	652	56,329	69,638	(75,721)
Accumulated balance consists of:
Translation loss						(62,099)
Pension and postretirement plans, net of taxes						(13,622)
Accumulated other comprehensive loss	(75,721)
Accumulated other comprehensive loss	(54,262)
Beginning balance at Jun. 30, 2021	83,535	6,475	634	56,507	74,181	(54,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	(445)				3,232	(3,677)
Repurchase of shares	(16)		(2)	(14)
Stock-based compensation	174	119		55
Conversion		25	(25)
Ending balance at Sep. 30, 2021	83,248	6,619	607	56,548	77,413	(57,939)
Beginning balance at Jun. 30, 2021	83,535	6,475	634	56,507	74,181	(54,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	12,147
Ending balance at Mar. 31, 2022	96,273	6,665	594	56,948	84,225	(52,159)
Beginning balance at Sep. 30, 2021	83,248	6,619	607	56,548	77,413	(57,939)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	1,590				2,528	(938)
Repurchase of shares	(7)			(7)
Stock-based compensation	237	11		226
Conversion		7	(7)
Issuance of stock	117	7	8	102
Ending balance at Dec. 31, 2021	85,185	6,644	608	56,869	79,941	(58,877)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive income (loss)	11,002				4,284	6,718
Repurchase of shares	(17)		(3)	(14)
Stock-based compensation	103	10		93
Conversion		11	(11)
Ending balance at Mar. 31, 2022	96,273	$ 6,665	$ 594	$ 56,948	$ 84,225	(52,159)
Accumulated balance consists of:
Translation loss						(53,722)
Pension and postretirement plans, net of taxes						$ 1,563
Accumulated other comprehensive loss	$ (52,159)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 10,044	$ 10,990
Non-cash operating activities:
Gain from sale of real estate	0	(3,204)
Depreciation	3,913	3,912
Amortization	957	911
Stock-based compensation	514	669
Net long-term tax obligations	126	117
Deferred taxes	937	(2,279)
Postretirement benefit and pension obligations	(1,058)	(11)
Changes in operating assets and liabilities:
Accounts receivable	(5,900)	(4,580)
Inventories	(11,053)	1,391
Other current assets	(5)	(1,813)
Other current liabilities	139	2,803
Prepaid pension expense	(2,342)	(6,374)
Other	937	189
Net cash (used in) provided by operating activities	(2,791)	2,721
Cash flows from investing activities:
Purchases of property, plant and equipment	(6,883)	(4,048)
Software development	(782)	(849)
Proceeds from sale of real estate	0	5,214
Net cash (used in) provided by investing activities	(7,665)	317
Cash flows from financing activities:
Proceeds from borrowings	39,875	12,581
Debt repayments	(29,488)	(17,924)
Proceeds from common stock issued	117	25
Shares repurchased	(40)	(11)
Net cash provided by (used in) financing activities	10,464	(5,329)
Effect of exchange rate changes on cash	(1,093)	80
Net decrease in cash	(1,085)	(2,211)
Cash, beginning of period	9,105	13,458
Cash, end of period	8,020	11,247
Supplemental cash flow information:
Interest paid	690	673
Income taxes paid, net	$ 2,614	$ 3,535

XML

Basis of Presentation and Summary of Significant Account Policies

9 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Basis of Presentation and Summary of Significant Account Policies

Basis of Presentation and Summary of Significant Account Policies

The unaudited interim consolidated financial statements as of and for the nine months ended March 31, 2022 have been prepared by The L.S. Starrett Company (the “Company”) in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements.  These unaudited consolidated financial statements, which, in the opinion of management, reflect all adjustments (including normal recurring adjustments) necessary for a fair presentation, should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021. The balance sheet as of June 30, 2021 has been derived from the audited consolidated financial statements as of and for the year ended June 30, 2021.  Operating results are not necessarily indicative of the results that may be expected for any future interim period or for the entire fiscal year. The Company’s “fiscal year” begins July 1st and ends June 30th.

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect amounts reported in the consolidated financial statements and accompanying notes.  Note 2 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended June 30, 2021 describes the significant accounting policies and methods used in the preparation of the consolidated financial statements.

Throughout the pandemic crisis, the Company's main focus has been on protecting the health and well-being of its employees, and the long-term financial health of the Company. It remains very difficult for management to predict when this crisis will no longer be a risk to future sales and operations. To the extent that pandemic-related events do not provide evidence about conditions that existed at the balance-sheet date, the Company considers it necessary to disclose it cannot estimate all aspects of the impact on the financial statements as a result of the on-going pandemic.

XML

Segment Information

9 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Segment Information

Segment Information

The segment information and the accounting policies of each segment are the same as those described in the notes to the consolidated financial statements entitled “Financial Information by Segment & Geographic Area” included in our Annual Report on Form 10-K for the year ended June 30, 2021. The Company’s business is aggregated into two reportable segments based on geography of operations: North American Operations and International Operations. Segment income is measured for internal reporting purposes by excluding corporate expenses, which are included in the unallocated column in the table below. Other income and expense, including interest income and expense, and income taxes are excluded entirely from the table below. There were no significant changes in the segment operations or in the segment assets from the Annual Report. Financial results for each reportable segment are as follows (in thousands):

	North American Operations		International Operations		Unallocated		Total
Three Months ended March 31, 2022
Sales1	$	36,288	$	24,191	$	—	$	60,479
Operating Income (Loss)	$	4,663	$	2,627	$	(1,917)	5,374
Three Months ended March 31, 2021
Sales2	$	32,519	$	22,425	$	—	$	54,944
Operating Income (Loss)	$	2,931	$	2,692	$	(1,773)	$	3,850

1.Excludes $1,148 of North American segment intercompany sales to the International segment, and $4,402 of International segment intercompany sales to the North American segment.

2.Excludes $1,338 of North American segment intercompany sales to the International segment, and $3,197 of International segment intercompany sales to the North American segment.

	North American Operations		International Operations		Unallocated		Total
Nine Months ended March 31, 2022
Sales1	$	102,763	$	80,548	$	—	$	183,311
Operating Income (Loss)	$	8,713	$	10,604	$	(5,611)	$	13,706
Nine months ended March 31, 2021
Sales2	$	85,609	$	72,799	$	—	$	158,408
Operating Income (Loss)	$	8,611	$	8,804	$	(5,529)	$	11,886

1.Excludes $2,827 of North American segment intercompany sales to the International segment, and $14,150 of International segment intercompany sales to the North American segment.

2.Excludes $3,075 of North American segment intercompany sales to the International segment, and $8,593 of International segment intercompany sales to the North American segment.

XML

Revenue from Contracts with Customers

9 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customer

Revenue from Contracts with Customers

Under ASC Topic 606, the Company is required to present a refund liability and a return asset within the Unaudited Consolidated Balance Sheet. As of March 31, 2022 and June 30, 2021, the balance of the return asset was $0.1 million and $0.2 million, respectively, and the balance of the refund liability as of March 31, 2022 and June 30, 2021 was $0.2 million. They are presented within prepaid expenses and other current assets and accrued expenses, respectively, on the Consolidated Balance Sheets.

The Company, in general, warrants its products against certain defects in material and workmanship when used as designed, for a period of up to one year. The Company does not sell extended warranties.

Contract Balances

Contract assets primarily relate to the Company’s rights to consideration for work completed but not billed at the reporting date on contracts with customers. Contract assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been met, and therefore, revenue has not been recognized. The Company had no contract asset balances, but had contract liability balances of $0.9 million and $0.6 million at March 31, 2022 and June 30, 2021, respectively, located in Accounts Payable in the Consolidated Balance Sheets.

Disaggregation of Revenue

The Company operates in two reportable segments: North America and International. ASC Topic 606 requires further disaggregation of an entity’s revenue. In the following table, the Company's net sales by shipping origin are disaggregated accordingly for the three months ended March 31, 2022 and 2021 (in thousands):

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
North America
United States	$	34,181	$	30,307	$	97,049	$	79,989
Canada & Mexico	2,107		2,212		5,714		5,620
	36,288		32,519		102,763		85,609
International
Brazil	15,980		14,901		54,063		47,302
United Kingdom	4,750		4,269		14,254		14,818
China	1,899		1,655		5,761		5,240
Australia & New Zealand	1,562		1,600		6,469		5,439
	24,191		22,425		80,548		72,799
Total Sales	$	60,479	$	54,944	$	183,311	$	158,408

XML

Recent Accounting Pronouncements

9 Months Ended

Mar. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard will replace today’s “incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The amendment will affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2018-19 clarifies that receivables arising from operating leases are accounted for using lease guidance and not as financial instruments. The amendments should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. This ASU is effective for annual periods beginning after December 15, 2019, and interim periods therein. Early adoption was permitted for annual periods beginning after December 15, 2018, and interim periods therein. This pronouncement was extended for Small Reporting Companies and for the Company to July 1, 2022. The adoption of this standard does not have a material impact on the financial position and results of operations.

In August 2018, the FASB issued ASU No. 2018-14, "Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans." ASU 2018-14 removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and added additional disclosures. This ASU was effective for the Company beginning July 1, 2021 and applied on a retrospective basis. The adoption of this standard did not have a material impact on the financial position and results of operations or the required disclosures.

XML

Leases

9 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Leases

Leases Operating lease cost amounted to $0.5 million and $2.1 million for the three and nine months period ended March 31, 2022 and $0.6 million and $1.8 million for the three and nine months period ended December 31, 2021. As of March 31, 2022, the Company’s right-of-use assets "ROU", lease obligations and remaining cash commitment on these leases (in thousands):

	Right-of-Use Assets	Operating Lease Obligations	Remaining Cash Commitment
Operating leases	$5,606	$5,766	$6,925

In March, the Company adopted a restructuring plan to close down Starrett Japan and Singapore operating units and continue to service that region out of Brazil and China with company agents servicing those countries. In the June quarter the Company expects to reduce its ROU asset and liabilities $0.1 million.

In September 2021, the Company entered into a six year lease in China for 100,682 square feet and recorded a right-of-use asset for $2.6 million. In July 2021, Starrett UK leased space to another company for annual rent of $0.2 million and incremental applicable service charges. The lease is a 20 year agreement with a contract review in 2026. The fees are recorded in Other Income in the Company's Consolidated Statement of Operations.

The Company has other operating lease agreements with commitments of less than one year or that are not significant. The Company elected the practical expedient option and as such, these lease payments are expensed as incurred. The Company’s weighted average discount rate and remaining term on lease liabilities is approximately 9.0% and 4.4 years. As of March 31, 2022, the Company’s financing leases are de minimis. The foreign exchange impact affecting the operating leases was de minimis in the March quarter and $0.1 million for the nine months ending March 31, 2022.

The Company entered into $0.2 million and $2.8 million in new operating lease commitments.

At March 31, 2022, the Company had the following fiscal year minimum operating lease commitments (in thousands)

Nine months ended March 31, 2022	Operating Lease Commitments
2022 (Remainder of year)	$552
2023	1,813
2024	1,541
2025	1,143
2026	1,050
Thereafter	826
Subtotal	$6,925
Imputed interest	(1,159)
Total	5,766

XML

Stock-based Compensation

9 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Stock-based Compensation

Stock-based Compensation

On September 5, 2012, the Board of Directors adopted The L.S. Starrett Company 2012 Long Term Incentive Plan (the “2012 Stock Plan”). The 2012 Stock Plan was approved by shareholders on October 17, 2012 and the material terms of its performance goals were re-approved by shareholders at the Company’s Annual Meeting held on October 18, 2017. There are no shares available under the 2012 Plan.

On September 1, 2021, the Board of Directors adopted The L.S. Starrett Company 2021 Long Term Incentive Plan (the “2021 Stock Plan”). The 2021 Stock Plan was approved by shareholders on October 13, 2021.

Both the 2012 and 2021 Stock Plan permits the granting of the following types of awards to officers, other employees and non-employee directors: stock options; restricted stock awards; unrestricted stock awards; stock appreciation rights; stock units including restricted stock units; performance awards; cash-based awards; and awards other than previously described that are convertible or otherwise based on stock. The 2021 and 2012 Stock Plans provide for the issuance of up to 500,000 shares of common stock.

Under both plans, options granted vest in periods ranging from one year to three years and expire ten years after the grant date. Restricted stock units (“RSU”) granted generally vest from one year to three years. Vested restricted stock units will be settled in shares of common stock. As of March 31, 2022, there were no stock options and 196,307 restricted stock units outstanding. There were 441,901 shares available for grant under the 2021 Stock Plan as of March 31, 2022.

For stock option grants, the fair value of each grant is estimated at the date of grant using the Binomial Options pricing model. The Binomial Options pricing model utilizes assumptions related to stock volatility, the risk-free interest rate, the dividend yield, and employee exercise behavior. Expected volatilities utilized in the model are based on the historic volatility of the Company’s stock price. The risk-free interest rate is derived from the U.S. Treasury Yield curve in effect at the time of the grant. The expected life is determined using the average of the vesting period and contractual term of the options (Simplified Method).

No stock options were granted during the nine months ended March 31, 2022 and 2021.

There were no stock options outstanding as of March 31, 2022. There were no stock options exercisable as of March 31, 2022. In recognizing stock compensation expense for the 2012 and 2021 Stock Incentive Plan, management has estimated that there will be no forfeitures of options.

The Company accounts for stock options and RSU awards by recognizing the expense of the grant date fair value ratably over vesting periods generally ranging from one year to three years. The related expense is included in selling, general and administrative expenses.

There were 80,500 RSU awards with a fair value of $11.35 per RSU granted during the nine months ended March 31, 2022. There were 133,995 RSUs settled, and 11,174 RSUs forfeited during the nine months ended March 31, 2022.  The aggregate intrinsic value of RSU awards outstanding as of March 31, 2022 was $1.5 million. As of March 31, 2022, all vested awards have been issued and settled.

On February 5, 2013, the Board of Directors adopted The L.S. Starrett Company 2013 Employee Stock Ownership Plan (the “2013 ESOP”). The purpose of the plan is to supplement existing Company programs through an employer funded individual account plan dedicated to investment in common stock of the Company, thereby encouraging increased ownership of the Company while providing an additional source of retirement income.  The plan is intended as an employee stock ownership plan within the meaning of Section 4975 (e) (7) of the Internal Revenue Code of 1986, as amended. U.S. employees who have completed a year of service are eligible to participate. There are no longer any new entrants into this plan.

Compensation expense related to all stock-based plans for the three and nine-month periods ended March 31, 2022 were $0.1 million and $0.4 million as compared to the prior year three and nine months of $0.1 million and $0.6 million, respectively.  As of March 31, 2022, there was $2.8 million of total unrecognized compensation costs related to outstanding stock-based compensation arrangements. Of this cost, $2.1 million relates to performance based RSU grants that are not expected to be awarded. The remaining $0.7 million is expected to be recognized over a weighted average period of 2.0 years.

XML

Inventories

9 Months Ended

Mar. 31, 2022

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consist of the following (in thousands):

	03/31/2022		06/30/2021
Raw material and supplies	$	36,064	$	29,271
Goods in process and finished parts	21,627		16,096
Finished goods	41,752		37,344
	99,443		82,711
LIFO Reserve	(26,368)		(22,139)
	$	73,075	$	60,572

Of the Company’s $73.1 million and $60.6 million total inventory at March 31, 2022 and June 30, 2021, respectively, the $26.4 million and  $22.1 million LIFO reserves belong to the U.S. Precision Tools and Saws Manufacturing “Core U.S.” business. The Core U.S. business total inventory was $37.5 million on a FIFO basis and $11.2 million on a LIFO basis at March 31, 2022. The Core U.S. business had total Inventory, on a FIFO basis, of $27.9 million and $5.7 million on a LIFO

basis as of June 30, 2021. The use of LIFO, as compared to FIFO, resulted in a $4.3 million increase in cost of sales for the goods sold in the period ending March 31, 2022 compared to $0.4 million increase in the nine months ended March 31, 2021.

XML

Goodwill and Intangible Assets

9 Months Ended

Mar. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

The Company’s acquisition of Bytewise in 2011 and a private software company in 2017 resulted in the recognition of goodwill totaling $4.7 million. During the fourth quarter of fiscal year 2020 the Company tested impairment of intangible assets according to ASC 360 "Property, Plant and Equipment" and determined the carrying value was deemed to be recoverable at Bytewise but not at the private software company where the impairment of intangibles was calculated. The Company concluded that intangible assets of the private software company were impaired by $2.9 million.

The Company then, according to ASC 350 Intangibles -Goodwill and Other, conducted a step one analysis performed based on the update carrying value for each reporting unit. Goodwill was determined to be impaired $0.6 million at the private software company and Goodwill of $3.0 million was impaired at the Bytewise reporting unit as of June 30, 2020. As a result, the balance of Goodwill at Bytewise is zero and $1.0 million at the private software company as of December 31, 2020.

The Company will continue to perform an annual assessment of goodwill associated with its purchase of a private software company. If future results significantly vary from current estimates, related projections, or business assumptions due to changes in industry or market conditions, the Company may be required to perform an impairment analysis prior to our annual test date if a triggering event is identified. As of March 31, 2022 , the Company did not identify a triggering event.

Amortizable intangible assets consist of the following (in thousands):

	03/31/2022		6/30/2021
Trademarks and trade names	2,070		2,070
Completed technology	—		2,010
Customer relationships	630		630
Software development	11,025		10,244
Total	13,725		14,954
Accumulated amortization and impairment	(9,012)		(10,066)
Total net balance	$	4,713	$	4,888

The category completed technology became fully amortized in November 2021. Amortizable intangible assets are being amortized on a straight-line basis over the period of expected economic benefit.

The estimated useful lives of the intangible assets subject to amortization range between 5 years for software development and 20 years for some trademark and trade name assets. The estimated aggregate amortization expense for the remainder of fiscal 2021 and for each of the next five years and thereafter, is as follows (in thousands):

2022 (Remainder of year)	$	359
2023	1,309
2024	1,039
2025	879
2026	669
2027	298
Thereafter	160
Total net balance	$	4,713

XML

Pension and Post-retirement Benefits

9 Months Ended

Mar. 31, 2022

Retirement Benefits [Abstract]

Pension and Post-retirement Benefits

Pension and Post-retirement Benefits

The Company has two defined benefit pension plans, one for U.S. employees and another for U.K. employees.  The Company has a postretirement medical insurance benefit plan for U.S. employees. The Company also has defined contribution plans.

The U.K. defined benefit plan was closed to new entrants in fiscal 2009.

On December 21, 2016, the Company amended the U.S. defined benefit pension plan to freeze benefit accruals effective December 31, 2016. Consequently, the Plan is closed to new participants and current participants will no longer earn additional benefits after December 31, 2016.

Net periodic benefit costs for the Company's defined benefit pension plans are located in Other (expense), net in Consolidated Statements of Operations except (in the table below) for service cost. Service cost are in cost of sales and selling, general and administrative expenses. Net periodic benefit costs consist of the following (in thousands):

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
Interest cost	1,026		1,120		3,090		3,351
Expected return on plan assets	(1,092)		(1,115)		(3,290)		(3,336)
Amortization of net loss	14		13		42		40
	$	(52)	$	18	$	(158)	$	55

Net periodic benefit costs for the Company's Postretirement Medical Plan consists of the following (in thousands):

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
Service cost	$	9	$	21	$	27	$	64
Interest cost	12		51		37		154
Amortization of prior service credit	(369)		(134)		(1,106)		(403)
Amortization of net loss	48		41		142		124
	$	(300)	$	(21)	$	(900)	$	(61)

For the three months ended March 31, 2022 the Company did not contribute in the U.S. to the pension plan and contributed $0.3 million in the UK. For the nine month periods ended March 31, 2022, the Company contributed $1.5 million, in the U.S. and $0.8 million in the UK pension plans. Based upon the actuarial valuations performed on the Company’s defined benefit plans as of June 30, 2021, the contribution for fiscal 2022 for the U.S. plans would require a contribution of $5.6 million and the U.K. plan would require one of $1.0 million. However, as a result of the American Rescue Plan Act of 2021, the minimum required company contribution for the U.S. Plan in fiscal 2022 was reduced from $5.6 million to $0.6 million. The Company believes that government regulation is only a small part of deciding the pension funding, and as a result, has contributed more than the federal requirement. The Company will evaluate the U.S. future contribution on a quarterly basis.

The Company’s pension plans use fair value as the market-related value of plan assets and recognize net actuarial gains or losses in excess of ten percent (10)% of the greater of the market-related value of plan assets or of the plans’ projected benefit obligation in net periodic (benefit) cost as of the plan measurement date. Net actuarial gains or losses that are less than 10% of the thresholds noted above are accounted for as part of accumulated other comprehensive loss.

XML

Debt

9 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Debt

Debt

Debt is comprised of the following (in thousands):

	03/31/2022		06/30/2021
Short-term and current maturities
Loan and Security Agreement (Line of credit)	15,013		9,153
Loan and Security Agreement (Term Loan)	1,660		1,509
Brazil Loans	6,159		5,297
	22,832		15,959
Long-term debt (net of current portion)
Loan and Security Agreement (Term Loan)	4,758		6,010
Brazil Loans	4,647		—
	9,405		6,010
	$	32,237	$	21,969

See Note 12 Subsequent events: On April 29, 2022, the Company and certain of the Company’s domestic subsidiaries entered into a new Loan and Security agreement with HSBC Bank USA.

On December 31, 2019, the Company entered into the Tenth Amendment of its Loan and Security Agreement (“Tenth Amendment”). Under the revised agreement, the credit limit for the Revolving Loan was increased from $23.0 million to $25.0 million. In addition, the Company entered into a new $10.0 million 5-year Term Loan with a fixed interest rate of 4.0%. Under the Tenth Amendment, the credit limit for external borrowing was increased from $2.5 million to $5.0 million.

On June 25, 2020, the Borrowers and TD Bank entered into an amendment and restatement (the “Amendment and Restatement”) of the Loan Agreement. The Amendment and Restatement waived the fixed charge coverage ratio for the quarter ended June 30, 2020. In addition, the Amendment and Restatement clarifies that certain non-cash adjustments to the definition of EBITDA are permitted under the Loan Agreement, as amended. In addition, the Amendment and Restatement increases the permitted borrowings from a foreign bank from $5.0 million to $15.0 million and permits the Company to draw the remainder of the outstanding balance under the Loan Agreement.

Pursuant to the terms of the Company’s Amended and Restated Loan and Security Agreement of June 25, 2020, the “First Amendment” to this loan agreement was executed on September 17, 2020, which include, among other things, (i) pause testing of the Fixed Charge Coverage Ratio until September 30, 2021 and (ii) establishment of a new minimum cumulative EBITDA and minimum liquidity covenants in lieu thereof. TD Bank updated its security interests in the Company’s U.S. based assets, increased the maximum interest charged on the Line Of Credit from an annual interest rate of 2.25% plus Libor to 3.50% plus Libor, and amended the borrowing base for the line of credit from 80% of Qualified AR and 50% of the lower of Cost or Market of US inventory values to 80% of qualified AR plus 85% of the Net Orderly Liquidation Value (NOLV) of US Inventory plus 62.5% of total appraised US real estate values.

As a result of this change, the Company is projected to maintain its current borrowing capacity of $25,000,000 under the Line of Credit. The Company underwent a series of appraisals and field exams in all US locations as part of restructuring this agreement and will provide additional reporting supporting the borrowing base and covenants certifications. This minimum adjusted EBITDA covenant was based on the Company’s plan for a slow pandemic recovery throughout FY21 and the impact of the Company’s restructuring plan initiatives. As of September 30, 2021, the agreement has reverted to the prior covenant package. The Company was compliant with the minimum liquidity requirement and the minimum fixed charge coverage ratio required bank covenants as of March 31, 2022.

Total debt increased $10.3 million during the nine months ended March 31, 2022, $5.5 million of which was an increase in Brazil. This is in response to increased working capital levels required to meet strong customer demand and counteract pandemic related supply chain disruptions and increased transit times.

During the nine months ended March 31, 2022 the Brazilian subsidiary realized a build-up of ICMS (sales tax) credits, a consequence of the fiscal 2021 restructuring activities which increased the manufacturing activity and, therefore, raw material imports into Brazil. As the Company's Brazilian subsidiary is now exporting a larger proportion of its sales, its ability to re-claim these ICMS credits has been diminished. The Company is actively mitigating this consequence by filing applications with the relevant tax authorities to change the methodology of charging and re-claiming ICMS on imports and domestic sales so that this credit is subsequently relieved and does not increase at this rate again. This new methodology is common for similar sized, export focused companies in Brazil.

Availability under the Line of Credit remains subject to a borrowing base comprised of Accounts Receivable, Inventory, and Real Estate. The Company believes that the borrowing base will consistently produce availability under the Line of Credit of $25.0 million. A 0.25% commitment fee is charged on the unused portion of the Line of Credit.

The Company’s Brazilian subsidiary incurs short-term loans with local banks in order to support the Company’s strategic initiatives. The loans are backed by the entity’s US dollar denominated export receivables. The Company’s Brazilian subsidiary has the following loans of March 31, 2022 (in thousands):

Lending Institution	Interest Rate	Beginning Date	Ending Date	Outstanding Balance
Banco do Brasil SA	2.80%	May 2021	May 2022	$	20
Banco Bradesco SA	1.88%	July 2021	July 2022	$	671
Banco Bradesco SA	2.05%	August 2021	July. 2022	$	284
Banco Santander (Brasil) S.A	2.15%	August 2021	July 2022	$	399
Banco do Brasil SA	2.10%	August 2021	August 2022	$	1,299
Banco Itaú Unibanco	4.52%	October 2021	September 2024	$	4,000
Banco Santander (Brasil) S.A	2.71%	December 2021	July 2022	$	1,000
Banco Bradesco SA	2.05%	January 2022	January 2023	$	1,000
Banco Itaú Unibanco	4.98%	February 2022	February 2024	2,133
				$	10,806

XML

Income Taxes

9 Months Ended

Mar. 31, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company is subject to U.S. federal income tax and various state, local, and foreign income taxes in numerous jurisdictions. The Company’s domestic and foreign tax liabilities are subject to the allocation of revenues and expenses in different jurisdictions and the timing of recognizing revenues and expenses. Additionally, the amount of income taxes paid is subject to the Company’s interpretation of applicable tax laws in the jurisdictions in which it files.

The Company provides for income taxes on an interim basis based on an estimate of the effective tax rate for the year. This estimate is reassessed on a quarterly basis. Discrete tax items are accounted for in the quarterly period in which they occur.

On December 22, 2017, the Tax Cuts and Jobs Act was enacted in the United States. The Act reduces the U.S. federal corporate tax rate from a graduated rate of 35% to a flat rate of 21%, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred and creates new taxes on certain foreign sourced earnings. Beginning in fiscal 2019, the Company incorporated certain provisions of the Act in the calculation of the tax provision and effective tax rate, including the provisions related to the Global Intangible Low Taxed Income (“GILTI”), Foreign Derived Intangible Income (“FDII”), Base Erosion Anti Abuse Tax (“BEAT”), as well as other provisions, which limit tax deductibility of expenses.

The GILTI provisions have had the most significant impact to the Company. Under the new law, U.S. taxes are imposed on foreign income in excess of a deemed return on tangible assets of its foreign subsidiaries. In general, this foreign income will effectively be taxed at an additional 10.5% tax rate reduced by any available current year foreign tax credits. The ability to benefit foreign tax credits may be limited under the GILTI rules as a result of the utilization of net operating losses, foreign sourced income and other potential limitations within the foreign tax credit calculation.

In July 2020, the IRS issued final regulations and additional proposed regulations that address the application of the high-taxed exclusion from GILTI. Under these regulations, the Company can make an annual election to exclude from its GILTI inclusion, income from its foreign subsidiaries that’s effective income tax rate exceeds 18.9% for that year. The regulations must be applied for tax years beginning after July 23, 2020 but companies have the option to apply retroactively for tax years beginning after December 31, 2017 and before July 23, 2020. In the first quarter of fiscal 2021 the Company recognized a discrete tax benefit of ($2.7) million related to the impact of electing to apply the high-tax exclusion retroactively for fiscal year 2019 and fiscal year 2020.

For the three month period ended March 31, 2022, the Company recognized tax expense of $1.8 million on a profit before tax of $6.1 million or an effective tax rate of 29%. For the three month period ended March 31, 2021, the Company recognized tax expense of $1.5 million on a profit before tax of $4.5 million or an effective tax rate of 33%. The tax rate for both fiscal 2022 and fiscal 2021 was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by tax credits and permanent deductions generated from research expenses.

For the nine month period ended March 31, 2022, the Company recognized tax expense of $3.9 million on a profit before tax of $14.0 million or an effective tax rate of 28%. This was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI

provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by discrete tax benefits recognized from excess stock compensation deductions, tax credits, and permanent deductions generated from research expenses. For the nine month period ended March 31, 2021. the Company recognized tax expense of $1.1 million on a profit before tax of $12.1 million or an effective tax rate of 9%.This was lower than the U.S. statutory tax rate of 21% primarily due to the discrete benefits relating to legislation enacted during the first quarter of fiscal 2021 in the amount of ($2.7) million related to the impact of the GILTI high-tax exclusion and ($0.2) million related to the impact of the increase in UK corporate tax rate on the net deferred tax asset. Other factors impacting the tax rate include the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by tax credits and permanent deductions generated from research expenses.

U.S. Federal tax returns for years prior to fiscal 2018 are generally no longer subject to review by tax authorities; however, tax loss carryforwards from earlier years are still subject to adjustment. As of March 31, 2022, the Company has substantially resolved all open income tax audits and there were no other local or federal income tax audits in progress. In international jurisdictions including Australia, Brazil, Canada, China, Germany, Mexico, New Zealand, Singapore and the UK, which comprise a significant portion of the Company’s operations, the years that may be examined vary by country. The Company’s most significant foreign subsidiary in Brazil is subject to audit for the calendar years 2015 – present. During the next twelve months, it is possible there will be a reduction of $0.1 million in long-term tax obligations due to the expiration of the statute of limitations on prior year tax returns.

Accounting for income taxes requires estimates of future benefits and tax liabilities. Due to the temporary differences in the timing of recognition of items included in income for accounting and tax purposes, deferred tax assets or liabilities are recorded to reflect the impact arising from these differences on future tax payments. With respect to recorded tax assets, the Company assesses the likelihood that the asset will be realized by addressing the positive and negative evidence to determine whether realization is more likely than not to occur. If realization is in doubt because of uncertainty regarding future profitability, the Company provides a valuation allowance related to the asset to the extent that it is more likely than not that the deferred tax asset will not be realized. Should any significant changes in the tax law or the estimate of the necessary valuation allowance occur, the Company would record the impact of the change, which could have a material effect on the Company’s financial position.

No valuation allowance has been recorded for the Company’s U.S. federal and foreign deferred tax assets related to temporary differences included in taxable income. While the Company continues to believe that forecasted future taxable income provide sufficient evidence to, more likely than not, support the realization of the tax benefits provided by those differences; the impact of COVID-19 may significantly impact its ability to forecast future pre-tax earnings in certain jurisdictions.

In the U.S., a partial valuation allowance has been provided for foreign tax credit carryforwards due to the uncertainty of generating sufficient foreign source income to utilize those credits in the future and certain state net operating loss carryforwards that will expire in the near future unutilized.

XML

Restructuring

9 Months Ended

Mar. 31, 2022

Restructuring and Related Activities [Abstract]

Restructuring

Restructuring

In March 2022, the Company adopted restructuring plans at a total projected cost of $1.6 million, of which $0.9 million related to the closure of its distribution and sales centers in Singapore and Japan, and $0.7 million for the refinancing of the Company's domestic credit facilities. The Company will continue to service Asia out of Brazil and China, and the plan is expected to be completed by June 30, 2022. The cost to close the Singapore and Japan operations is comprised of $0.6 million in headcount reduction, $0.2 in fixed asset and lease disposal, and $0.1 million in professional fees The Company anticipates an annualized savings reflected in the Consolidated Statements of Operations in Selling, General and Administrative expenses for this project of $0.6 million.

In the quarter ending March 31, 2022, the Company recorded $0.7 million in restructuring charges, of which $0.4 million was accrued and $0.1 million was incurred in relation to headcount reduction costs related to the Singapore and Japan closure and $0.2 million was incurred in relation to the refinancing of the Company's domestic credit facilities. Additional restructuring charges anticipated for both the Japan and Singapore closure and the residual amount for the refinancing of the Company's domestic credit facilities will be recorded as incurred in the quarter ending June 30, 2022.

XML

Contingencies	9 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	ContingenciesThe Company is involved in certain legal matters, which arise, in the normal course of business. The Company does not believe it is reasonably possible that these matters will have a material impact on the Company's financial condition or cash flows

XML

Subsequent Events

9 Months Ended

Mar. 31, 2022

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

On April 29, 2022, the Company and certain of the Company’s domestic subsidiaries entered into a new Loan and Security agreement with HSBC Bank USA.

These new credit facilities replaced the Company’s previous TD Bank credit facilities and are comprised of a $30 million revolving line of credit with a $10 million uncommitted accordion provision, a $12.1 million term loan and a $7 million Capital Expenditure draw down credit facility. The Facilities are secured by a valid first-priority security interest on substantially all existing and future assets of the Company and its domestic subsidiaries.

The interest rate on the new facilities is based on a grid which uses the percentage of the remaining availability of the revolving credit line to determine the floating margin to be added to the one month or three-month Secured Overnight Financing Rate, herein "SOFR". The initial rate for the first three months of the agreement is the one-month SOFR plus 1.60%. The new credit facilities mature on April 29, 2027.

Availability under the revolving line of credit is secured by and subject to a borrowing base comprised of eligible inventory and accounts receivable. The percentage of receivables included in the borrowing base is 90% for domestic investment grade and foreign insured accounts, 85% for domestic accounts that are neither investment grade nor insured, and 75% of foreign uninsured accounts. The percentage of inventory included in the borrowing base is the lower of 65% of the value of eligible inventory at cost or 85% of the net orderly liquidation value of eligible inventory at cost. The initial borrowing base is estimated at about $19 million. Receivables and inventory are reported monthly to HSBC and subject to an annual field exam and inventory appraisal by an independent auditor commissioned by the Bank. The Company believes that the agreement provides an initial borrowing base sufficient for current domestic working capital needs and flexibility to accommodate potential growth-related working capital needs.

Availability under the Term Loan facility was comprised of 70% of the fair market value of the Borrowers’ eligible real estate, which included facilities located in Westlake, Ohio, and Waite Park, Minnesota and totaled $4.6 million; and 85% of the net orderly liquidation value of the Borrowers’ machinery and equipment, capped at $7.5 million. The real estate portion of the Term facility is subject to a 12.5 year straight line amortization paid quarterly, and the machinery and equipment portion of the facility is subject to a 6.67 year straight line amortization, also paid quarterly. The term loan is subject to equal quarterly installments of $373,650, payable on the last day of each fiscal quarter.

The capital expenditure loan facility is available for the purchase of new machinery and equipment at 80% of the net invoice value of new machinery and equipment purchases, with a draw period of eighteen months past the closing date, with any amount outstanding under the facility subject to a 3.75% amortization rate per quarter.

The new credit facilities contain financial covenants with respect to a minimum fixed charge coverage ratio of 1.00, measured on a trailing twelve-month basis, for both the U.S. borrowing companies tested quarterly and the Consolidated L.S. Starrett Company tested semi-annually. The Loan and Security agreement also contains the customary affirmative and negative covenants, including limitations on indebtedness, liens, acquisitions, asset dispositions, fundamental corporate changes, excess pension contributions, and certain customary events of default. Upon the occurrence or continuation of an event of default, the Lender may terminate all commitments and facilities, and require the immediate payment of the entire unpaid principal balances, accrued interest, and all other obligations.

XML

Basis of Presentation and Summary of Significant Account Policies (Policies)

9 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Basis of Accounting

The unaudited interim consolidated financial statements as of and for the nine months ended March 31, 2022 have been prepared by The L.S. Starrett Company (the “Company”) in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements.  These unaudited consolidated financial statements, which, in the opinion of management, reflect all adjustments (including normal recurring adjustments) necessary for a fair presentation, should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021. The balance sheet as of June 30, 2021 has been derived from the audited consolidated financial statements as of and for the year ended June 30, 2021.  Operating results are not necessarily indicative of the results that may be expected for any future interim period or for the entire fiscal year. The Company’s “fiscal year” begins July 1st and ends June 30th.

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect amounts reported in the consolidated financial statements and accompanying notes.  Note 2 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended June 30, 2021 describes the significant accounting policies and methods used in the preparation of the consolidated financial statements.

Potential Impairment Due to COVID-19

Throughout the pandemic crisis, the Company's main focus has been on protecting the health and well-being of its employees, and the long-term financial health of the Company. It remains very difficult for management to predict when this crisis will no longer be a risk to future sales and operations. To the extent that pandemic-related events do not provide evidence about conditions that existed at the balance-sheet date, the Company considers it necessary to disclose it cannot estimate all aspects of the impact on the financial statements as a result of the on-going pandemic.

Recently Issued Accounting Standards not yet adopted

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard will replace today’s “incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The amendment will affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2018-19 clarifies that receivables arising from operating leases are accounted for using lease guidance and not as financial instruments. The amendments should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. This ASU is effective for annual periods beginning after December 15, 2019, and interim periods therein. Early adoption was permitted for annual periods beginning after December 15, 2018, and interim periods therein. This pronouncement was extended for Small Reporting Companies and for the Company to July 1, 2022. The adoption of this standard does not have a material impact on the financial position and results of operations.

In August 2018, the FASB issued ASU No. 2018-14, "Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans." ASU 2018-14 removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and added additional disclosures. This ASU was effective for the Company beginning July 1, 2021 and applied on a retrospective basis. The adoption of this standard did not have a material impact on the financial position and results of operations or the required disclosures.

XML

Segment Information (Tables)

9 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Summary of financial results for reportable segments

Financial results for each reportable segment are as follows (in thousands):

	North American Operations		International Operations		Unallocated		Total
Three Months ended March 31, 2022
Sales1	$	36,288	$	24,191	$	—	$	60,479
Operating Income (Loss)	$	4,663	$	2,627	$	(1,917)	5,374
Three Months ended March 31, 2021
Sales2	$	32,519	$	22,425	$	—	$	54,944
Operating Income (Loss)	$	2,931	$	2,692	$	(1,773)	$	3,850

1.Excludes $1,148 of North American segment intercompany sales to the International segment, and $4,402 of International segment intercompany sales to the North American segment.

2.Excludes $1,338 of North American segment intercompany sales to the International segment, and $3,197 of International segment intercompany sales to the North American segment.

	North American Operations		International Operations		Unallocated		Total
Nine Months ended March 31, 2022
Sales1	$	102,763	$	80,548	$	—	$	183,311
Operating Income (Loss)	$	8,713	$	10,604	$	(5,611)	$	13,706
Nine months ended March 31, 2021
Sales2	$	85,609	$	72,799	$	—	$	158,408
Operating Income (Loss)	$	8,611	$	8,804	$	(5,529)	$	11,886

1.Excludes $2,827 of North American segment intercompany sales to the International segment, and $14,150 of International segment intercompany sales to the North American segment.

2.Excludes $3,075 of North American segment intercompany sales to the International segment, and $8,593 of International segment intercompany sales to the North American segment.

XML

Revenue from Contracts with Customers (Tables)

9 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of revenue

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
North America
United States	$	34,181	$	30,307	$	97,049	$	79,989
Canada & Mexico	2,107		2,212		5,714		5,620
	36,288		32,519		102,763		85,609
International
Brazil	15,980		14,901		54,063		47,302
United Kingdom	4,750		4,269		14,254		14,818
China	1,899		1,655		5,761		5,240
Australia & New Zealand	1,562		1,600		6,469		5,439
	24,191		22,425		80,548		72,799
Total Sales	$	60,479	$	54,944	$	183,311	$	158,408

XML

Leases (Tables)

9 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Summary of lease assets and liabilities

As of March 31, 2022, the Company’s right-of-use assets "ROU", lease obligations and remaining cash commitment on these leases (in thousands):

	Right-of-Use Assets	Operating Lease Obligations	Remaining Cash Commitment
Operating leases	$5,606	$5,766	$6,925

Fiscal year minimum operating lease commitments

At March 31, 2022, the Company had the following fiscal year minimum operating lease commitments (in thousands)

Nine months ended March 31, 2022	Operating Lease Commitments
2022 (Remainder of year)	$552
2023	1,813
2024	1,541
2025	1,143
2026	1,050
Thereafter	826
Subtotal	$6,925
Imputed interest	(1,159)
Total	5,766

XML

Inventories (Tables)

9 Months Ended

Mar. 31, 2022

Inventory Disclosure [Abstract]

Schedule of inventories

Inventories consist of the following (in thousands):

	03/31/2022		06/30/2021
Raw material and supplies	$	36,064	$	29,271
Goods in process and finished parts	21,627		16,096
Finished goods	41,752		37,344
	99,443		82,711
LIFO Reserve	(26,368)		(22,139)
	$	73,075	$	60,572

XML

Goodwill and Intangible Assets (Tables)

9 Months Ended

Mar. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Amortizable intangible assets

Amortizable intangible assets consist of the following (in thousands):

	03/31/2022		6/30/2021
Trademarks and trade names	2,070		2,070
Completed technology	—		2,010
Customer relationships	630		630
Software development	11,025		10,244
Total	13,725		14,954
Accumulated amortization and impairment	(9,012)		(10,066)
Total net balance	$	4,713	$	4,888

Estimated aggregate amortization expense

The estimated aggregate amortization expense for the remainder of fiscal 2021 and for each of the next five years and thereafter, is as follows (in thousands):

2022 (Remainder of year)	$	359
2023	1,309
2024	1,039
2025	879
2026	669
2027	298
Thereafter	160
Total net balance	$	4,713

XML

Pension and Post-retirement Benefits (Tables)

9 Months Ended

Mar. 31, 2022

Retirement Benefits [Abstract]

Schedule of net benefit costs

Net periodic benefit costs consist of the following (in thousands):

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
Interest cost	1,026		1,120		3,090		3,351
Expected return on plan assets	(1,092)		(1,115)		(3,290)		(3,336)
Amortization of net loss	14		13		42		40
	$	(52)	$	18	$	(158)	$	55

Net periodic benefit costs for the Company's Postretirement Medical Plan consists of the following (in thousands):

	Three Months Ended				Nine Months Ended
	03/31/2022		03/31/2021		03/31/2022		03/31/2021
Service cost	$	9	$	21	$	27	$	64
Interest cost	12		51		37		154
Amortization of prior service credit	(369)		(134)		(1,106)		(403)
Amortization of net loss	48		41		142		124
	$	(300)	$	(21)	$	(900)	$	(61)

XML

Debt (Tables)

9 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Debt schedule

Debt is comprised of the following (in thousands):

	03/31/2022		06/30/2021
Short-term and current maturities
Loan and Security Agreement (Line of credit)	15,013		9,153
Loan and Security Agreement (Term Loan)	1,660		1,509
Brazil Loans	6,159		5,297
	22,832		15,959
Long-term debt (net of current portion)
Loan and Security Agreement (Term Loan)	4,758		6,010
Brazil Loans	4,647		—
	9,405		6,010
	$	32,237	$	21,969

Schedule of short-term debt, Brazilian subsidiary

The Company’s Brazilian subsidiary has the following loans of March 31, 2022 (in thousands):

Lending Institution	Interest Rate	Beginning Date	Ending Date	Outstanding Balance
Banco do Brasil SA	2.80%	May 2021	May 2022	$	20
Banco Bradesco SA	1.88%	July 2021	July 2022	$	671
Banco Bradesco SA	2.05%	August 2021	July. 2022	$	284
Banco Santander (Brasil) S.A	2.15%	August 2021	July 2022	$	399
Banco do Brasil SA	2.10%	August 2021	August 2022	$	1,299
Banco Itaú Unibanco	4.52%	October 2021	September 2024	$	4,000
Banco Santander (Brasil) S.A	2.71%	December 2021	July 2022	$	1,000
Banco Bradesco SA	2.05%	January 2022	January 2023	$	1,000
Banco Itaú Unibanco	4.98%	February 2022	February 2024	2,133
				$	10,806

XML

Segment Information - Narrative (Details)	9 Months Ended
	Mar. 31, 2022 segment
Segment Reporting [Abstract]
Number of reportable segments	2

XML

Segment Information - Summary of financial results for reportable segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Sales	$ 60,479	$ 54,944	$ 183,311	$ 158,408
Operating Income (Loss)	5,374	3,850	13,706	11,886
Unallocated
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Sales	0	0	0	0
Operating Income (Loss)	(1,917)	(1,773)	(5,611)	(5,529)
North American Operations
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Sales	36,288	32,519	102,763	85,609
North American Operations | Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Sales	36,288	32,519	102,763	85,609
Operating Income (Loss)	4,663	2,931	8,713	8,611
North American Operations | Intercompany sales
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Intercompany sales	1,148	1,338	2,827	3,075
International Operations | Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Sales	24,191	22,425	80,548	72,799
Operating Income (Loss)	2,627	2,692	10,604	8,804
International Operations | Intercompany sales
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Intercompany sales	$ 4,402	$ 3,197	$ 14,150	$ 8,593

XML

Revenue from Contracts with Customers - Narrative (Details)	9 Months Ended
	Mar. 31, 2022 USD ($) segment	Jun. 30, 2021 USD ($)
Revenue from Contract with Customer [Abstract]
Customer return asset	$ 100,000	$ 200,000
Customer refund liability	200,000	200,000
Contract asset	0	0
Contract liability	$ 900,000	$ 600,000
Number of reportable segments | segment	2

XML

Revenue from Contracts with Customers - Disaggregation of revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Net sales	$ 60,479	$ 54,944	$ 183,311	$ 158,408
North America
Disaggregation of Revenue [Line Items]
Net sales	36,288	32,519	102,763	85,609
International
Disaggregation of Revenue [Line Items]
Net sales	24,191	22,425	80,548	72,799
United States | North America
Disaggregation of Revenue [Line Items]
Net sales	34,181	30,307	97,049	79,989
Canada & Mexico | North America
Disaggregation of Revenue [Line Items]
Net sales	2,107	2,212	5,714	5,620
Brazil | International
Disaggregation of Revenue [Line Items]
Net sales	15,980	14,901	54,063	47,302
United Kingdom | International
Disaggregation of Revenue [Line Items]
Net sales	4,750	4,269	14,254	14,818
China | International
Disaggregation of Revenue [Line Items]
Net sales	1,899	1,655	5,761	5,240
Australia & New Zealand | International
Disaggregation of Revenue [Line Items]
Net sales	$ 1,562	$ 1,600	$ 6,469	$ 5,439

XML

Leases - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($) ft²	Jul. 31, 2021 USD ($)	Jun. 30, 2021 USD ($)
Lessee, Lease, Description [Line Items]
Operating lease cost	$ 500	$ 600	$ 2,100
Right of use assets	5,606		5,606				$ 4,298
Operating lease obligations	$ 5,766		$ 5,766
Weighted average discount rate	9.00%		9.00%
Weighted average remaining lease term	4 years 4 months 24 days		4 years 4 months 24 days
Foreign exchange impact affecting operating leases			$ 100
Operating lease commitments	$ 200		$ 2,800
China
Lessee, Lease, Description [Line Items]
Right of use assets					$ 2,600
Operating lease term					6 years
Square footage leased | ft²					100,682
United Kingdom
Lessee, Lease, Description [Line Items]
Annual rent income from lease						$ 200
Term of UK lease contract						20 years
Japan and Singapore | Facility Closing | Forecast
Lessee, Lease, Description [Line Items]
Right of use assets				$ 100
Operating lease obligations				$ 100

XML

Leases - Summary of lease assets and liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Right-of-Use Assets	$ 5,606	$ 4,298
Operating Lease Obligations	5,766
Remaining Cash Commitment	$ 6,925

XML

Leases - Fiscal year minimum operating lease commitments (Details) $ in Thousands	Mar. 31, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2022 (Remainder of year)	$ 552
2023	1,813
2024	1,541
2025	1,143
2026	1,050
Thereafter	826
Subtotal	6,925
Imputed interest	(1,159)
Operating lease obligations	$ 5,766

XML

Stock-based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Sep. 05, 2012
The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Shares of common stock authorized by 2012 and 2021 plans (in shares)					500,000
Shares outstanding (in shares)	0		0
Stock options exercisable (in shares)	0		0
Compensation expense related to stock-based plans	$ 0.1	$ 0.1	$ 0.4	$ 0.6
Unrecognized stock-based compensation costs	$ 0.7		$ 0.7
Expected weighted average vesting period (in years)			2 years
The 2021 Stock Incentive Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Shares available for grant under 2012 plan (in shares)	441,901		441,901
Share-based Payment Arrangement, Option | The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Expiration date of options granted (in years)			10 years
Shares outstanding (in shares)	0		0
Stock options granted (in shares)			0	0
Forfeiture of options (in shares)			0
Restricted Stock Units (RSUs) | The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Shares outstanding (in shares)	196,307		196,307
Restricted stock awards (in shares)			80,500
Fair value of restricted stock award grants (in dollars per share)			$ 11.35
Restricted stock awards vested (in shares)			133,995
Restricted stock awards forfeited (in shares)			11,174
Aggregate intrinsic value of shares outstanding (less than)	$ 1.5		$ 1.5
Unrecognized stock-based compensation costs	2.8		2.8
Portion Relating to RSU Grants Not Expected to be Awarded | The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Unrecognized stock-based compensation costs	$ 2.1		$ 2.1
Minimum | Share-based Payment Arrangement, Option | The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Vesting period of shares granted (in years)			1 year
Minimum | Restricted Stock Units (RSUs) | The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Vesting period of shares granted (in years)			1 year
Maximum | Share-based Payment Arrangement, Option | The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Vesting period of shares granted (in years)			3 years
Maximum | Restricted Stock Units (RSUs) | The 2012 and 2021 Stock Incentive Plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Vesting period of shares granted (in years)			3 years

XML

Inventories - Components of Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Inventory Disclosure [Abstract]
Raw material and supplies	$ 36,064	$ 29,271
Goods in process and finished parts	21,627	16,096
Finished goods	41,752	37,344
Total before LIFO reserve	99,443	82,711
LIFO Reserve	(26,368)	(22,139)
Total	$ 73,075	$ 60,572

XML

Inventories - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2022	Jun. 30, 2021
Inventory Disclosure [Abstract]
Inventories		$ 73,075	$ 60,572
LIFO reserves		26,368	22,139
Inventory difference using FIFO basis		37,500	27,900
LIFO inventory amount		$ 11,200	$ 5,700
Effect of LIFO Reserve on income	$ 400

XML

Goodwill and Intangible Assets - Narrative (Details) - USD ($)	3 Months Ended	9 Months Ended
	Jun. 30, 2020	Mar. 31, 2022	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Goodwill		$ 1,015,000	$ 1,015,000
Bytewise and Private Software Company
Finite-Lived Intangible Assets [Line Items]
Goodwill					$ 4,700,000
Private Software Company
Finite-Lived Intangible Assets [Line Items]
Goodwill				$ 1,000,000
Impairment of intangible assets	$ 2,900,000
Goodwill impairment loss	600,000
Bytewise
Finite-Lived Intangible Assets [Line Items]
Goodwill				$ 0
Goodwill impairment loss	$ 3,000,000
Computer software
Finite-Lived Intangible Assets [Line Items]
Intangible asset useful life		5 years
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Intangible asset useful life		20 years

XML

Goodwill and Intangible Assets - Finite-lived Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Total	$ 13,725	$ 14,954
Accumulated amortization and impairment	(9,012)	(10,066)
Total net balance	4,713	4,888
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Total	2,070	2,070
Completed technology
Finite-Lived Intangible Assets [Line Items]
Total	0	2,010
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Total	630	630
Software development
Finite-Lived Intangible Assets [Line Items]
Total	$ 11,025	$ 10,244

XML

Goodwill and Intangible Assets - Estimated Aggregate Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (Remainder of year)	$ 359
2023	1,309
2024	1,039
2025	879
2026	669
2027	298
Thereafter	160
Total net balance	$ 4,713	$ 4,888

XML

Pension and Post-retirement Benefits - Narrative (Details)	3 Months Ended	9 Months Ended
	Mar. 31, 2022 USD ($) plan	Mar. 31, 2022 USD ($) plan	Jun. 30, 2021 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of defined benefit pension plans | plan	2	2
Pension Plan | United States
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 0	$ 1,500,000
Expected employer contributions for next fiscal year			$ 5,600,000
Expected future contributions for current fiscal year, after legislation	600,000	600,000
Pension Plan | Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 300,000	$ 800,000
Expected employer contributions for next fiscal year			$ 1,000,000

XML

Pension and Post-retirement Benefits - Net Periodic Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 1,026	$ 1,120	$ 3,090	$ 3,351
Expected return on plan assets	(1,092)	(1,115)	(3,290)	(3,336)
Amortization of net loss	14	13	42	40
Total	(52)	18	(158)	55
Post Retirement Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	9	21	27	64
Interest cost	12	51	37	154
Amortization of prior service credit	(369)	(134)	(1,106)	(403)
Amortization of net loss	48	41	142	124
Total	$ (300)	$ (21)	$ (900)	$ (61)

XML

Debt - Debt Schedule (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Short-term Debt [Abstract]
Loan and Security Agreement	$ 22,832	$ 15,959
Brazil Loans	10,806
Short-term and current maturities	22,832	15,959
Long-term Debt, Excluding Current Maturities [Abstract]
Long-term debt, net of current portion	9,405	6,010
Long-term debt	32,237	21,969
Loan and Security Agreement (Term Loan)
Long-term Debt, Excluding Current Maturities [Abstract]
Long-term debt, net of current portion	4,758	6,010
Brazil Loans
Long-term Debt, Excluding Current Maturities [Abstract]
Long-term debt, net of current portion	4,647	0
Loan and Security Agreement (Line of credit)
Short-term Debt [Abstract]
Loan and Security Agreement	15,013	9,153
Loan and Security Agreement (Term Loan)
Short-term Debt [Abstract]
Loan and Security Agreement	1,660	1,509
Brazil Loans
Short-term Debt [Abstract]
Brazil Loans	$ 6,159	$ 5,297

XML

Debt - Narrative (Details) - USD ($)			9 Months Ended
	Jun. 25, 2020	Dec. 31, 2019	Mar. 31, 2022	Jun. 24, 2020	Dec. 30, 2019
Debt Instrument [Line Items]
Credit limit on revolving loan facility		$ 25,000,000	$ 25,000,000		$ 23,000,000
Commitment fee percentage on line of credit			0.25%
Loan and Security Agreement
Debt Instrument [Line Items]
Term loan				$ 5,000,000
Amended and Restated Loan and Security Agreement, Foreign Bank Term Loan
Debt Instrument [Line Items]
Term loan	$ 15,000,000
Amended and Restated Loan and Security Agreement, Term Loan | London Interbank Offered Rate (LIBOR) | Minimum
Debt Instrument [Line Items]
Variable interest rate	2.25%
Amended and Restated Loan and Security Agreement, Term Loan | London Interbank Offered Rate (LIBOR) | Maximum
Debt Instrument [Line Items]
Variable interest rate	3.50%
All Debt
Debt Instrument [Line Items]
Increase in debt			$ 10,300,000
Brazil Debt
Debt Instrument [Line Items]
Increase in debt			5,500,000
Term Loan
Debt Instrument [Line Items]
Term loan		$ 10,000,000
Term of loan		5 years
Fixed interest rate		4.00%
Credit limit for external borrowing		$ 5,000,000			$ 2,500,000
Line of Credit | Loan and Security Agreement
Debt Instrument [Line Items]
Percent of qualified AR				80.00%
Percent of the lower of Cost or Market of US Inventory values				50.00%
Line of Credit | Amended and Restated Loan and Security Agreement, Term Loan
Debt Instrument [Line Items]
Credit limit on revolving loan facility			$ 25,000,000
Percent of qualified AR	80.00%
Percent of Net Orderly Liquidation Value (NOLV)	85.00%
Percent of US real estate values	62.50%

XML

Debt - Short-term Debt (Details) $ in Thousands	Mar. 31, 2022 USD ($)
Statement [Line Items]
Brazil Loans	$ 10,806
Banco do Brasil SA | 2.80% Short-term loan
Statement [Line Items]
Interest rate	2.80%
Brazil Loans	$ 20
Banco do Brasil SA | 2.10% Short-term loan
Statement [Line Items]
Interest rate	2.10%
Brazil Loans	$ 1,299
Banco Bradesco SA | 1.88% Short-term loan
Statement [Line Items]
Interest rate	1.88%
Brazil Loans	$ 671
Banco Bradesco SA | 2.05% Short-term loan Aug 2021
Statement [Line Items]
Interest rate	2.05%
Brazil Loans	$ 284
Banco Bradesco SA | 2.05% Short-term loan Jan 2022
Statement [Line Items]
Interest rate	2.05%
Brazil Loans	$ 1,000
Banco Santander (Brasil) SA | 2.15% Short-term loan
Statement [Line Items]
Interest rate	2.15%
Brazil Loans	$ 399
Banco Santander (Brasil) SA | 2.71% Short-term loan
Statement [Line Items]
Interest rate	2.71%
Brazil Loans	$ 1,000
Banco Itau Unibanco | 4.52% Short-term loan
Statement [Line Items]
Interest rate	4.52%
Brazil Loans	$ 4,000
Banco Itau Unibanco | 4.98% Short-term loan
Statement [Line Items]
Interest rate	4.98%
Brazil Loans	$ 2,133

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Mar. 31, 2022	Mar. 31, 2021
Operating Loss Carryforwards [Line Items]
Effective income tax rate percentage	29.00%	18.90%	33.00%		28.00%	9.00%
Income tax expense	$ 1,774		$ 1,496		$ 3,911	$ 1,132
Profit before tax	6,100		$ 4,500		14,000	$ 12,100
Possible reduction in long-term tax obligations	$ 100				$ 100
Tax Years 2019 and 2020
Operating Loss Carryforwards [Line Items]
Income tax expense		$ (2,700)		$ (2,700)
Foreign Tax Authority | Her Majesty's Revenue and Customs (HMRC)
Operating Loss Carryforwards [Line Items]
Effect of increase in UK corporate tax rate		$ (200)

XML

Restructuring (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 658	$ 788	$ 658	$ 1,518
2022 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs	$ 1,600	1,600		1,600
Restructuring charges	700
Expected annual savings		600
Accrued restructuring costs	400	400		400
Closure of Distribution and Sales Centers | 2022 Restructuring Plan | Japan and Singapore
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs	900	900		900
Debt Refinancing | 2022 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs	700	700		$ 700
Restructuring costs charged as period expense	200
Headcount Reduction | 2022 Restructuring Plan | Japan and Singapore
Restructuring Cost and Reserve [Line Items]
Restructuring charges		600
Restructuring costs charged as period expense	$ 100
Fixed Asset and Lease Disposal | 2022 Restructuring Plan | Japan and Singapore
Restructuring Cost and Reserve [Line Items]
Restructuring charges		200
Professional Fees | 2022 Restructuring Plan | Japan and Singapore
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 100

XML

Subsequent Events (Details) - USD ($)	Apr. 29, 2022	Mar. 31, 2022	Jun. 24, 2020	Dec. 31, 2019	Dec. 30, 2019
Subsequent Event [Line Items]
Credit limit on revolving loan facility		$ 25,000,000		$ 25,000,000	$ 23,000,000
Loan and Security Agreement
Subsequent Event [Line Items]
Term loan			$ 5,000,000
Revolving Credit Facility | Subsequent Event | Loan and Security Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Subsequent Event [Line Items]
Variable interest rate	1.60%
Line of Credit | Subsequent Event | Loan and Security Agreement
Subsequent Event [Line Items]
Minimum fixed charge coverage ratio	100.00%
Line of Credit | Revolving Credit Facility | Subsequent Event | Loan and Security Agreement
Subsequent Event [Line Items]
Percentage of receivables included in borrowing base, investment grade	90.00%
Percentage of receivables included in borrowing base, domestic investment grade and foreign insured	85.00%
Percentage of receivables included in borrowing base, foreign uninsured	75.00%
Percentage of eligible inventory included in borrowing base at cost	65.00%
Percentage of eligible inventory included in borrowing base at net orderly liquidation value	85.00%
Current borrowing base availability	$ 19,000,000
Line of Credit | Revolving Credit Facility | HSBC Bank USA | Subsequent Event
Subsequent Event [Line Items]
Credit limit on revolving loan facility	30,000,000
Accordion feature	$ 10,000,000
Line of Credit | Term Loan | Subsequent Event | Loan and Security Agreement
Subsequent Event [Line Items]
Percentage of the fair market value of eligible real estate	70.00%
Fair value of real estate	$ 4,600,000
Percentage of net orderly liquidation value of machinery and equipment	85.00%
Capped value of eligible machinery and equipment	$ 7,500,000
Amortization period for real estate portion	12 years 6 months
Amortization period for machinery and equipment portion	6 years 8 months 1 day
Quarterly term loan payments	$ 373,650
Line of Credit | Term Loan | HSBC Bank USA | Subsequent Event
Subsequent Event [Line Items]
Credit limit on revolving loan facility	$ 12,100,000
Line of Credit | Capital Expenditure Draw Down Credit Facility | Subsequent Event | Loan and Security Agreement
Subsequent Event [Line Items]
Percentage of eligible new machinery and equipment	80.00%
Draw down period	18 months
Amortization rate for capital expenditure draw amounts outstanding	3.75%
Line of Credit | Capital Expenditure Draw Down Credit Facility | HSBC Bank USA | Subsequent Event
Subsequent Event [Line Items]
Credit limit on revolving loan facility	$ 7,000,000